Persons encountering health services for other counselling and medical advice, not elsewhere classified

Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_COUNSELLI_MEDICAL_ADVICE_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z71 Cause of death: ICD-10 — Z71 2 out of 7 registries used, show all original rules.	79154
4. Check minimum number of events None	79154
5. Include endpoints None	79154
6. Filter based on genotype QC (FinnGen only)	79154

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z7

NAME	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_COUNSELLI_MEDICAL_ADVICE_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z71
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z71
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Persons encountering health services for other counselling and medical advice, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Alcohol abuse counselling and surveillance

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	79154	51661	27493
Unadjusted period prevalence (%)	15.70	17.61	12.12
Median age at first event (years)	52.70	48.50	60.60

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
38074: Matched controls
242840

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

323.0

10928

42455

Z71.8

ICD-10 Finland

Other specified counselling

33.0

323.0

24595

12729

R4110

NOMESCO Finland

Physiotherapy

1.7

323.0

9310

38227

R06.0

ICD-10 Finland

Dyspnoea

1.8

323.0

8620

33285

RF410

NOMESCO Finland

22.0

323.0

896

266

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

323.0

5305

17930

RD211

NOMESCO Finland

28.9

323.0

4527

1129

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

323.0

8324

29791

RF420

NOMESCO Finland

11.2

323.0

863

500

S15

ICPC

Foreign body in skin

3.1

323.0

2544

5496

SPAT1216

SPAT

Assessment of functional ability

2.5

323.0

6379

17763

N02AA05

ATC

oxycodone; systemic

2.0

323.0

5296

18052

R03AC02

ATC

salbutamol; inhalant

1.6

323.0

17065

83381

C07AB07

ATC

bisoprolol; oral

1.7

323.0

17064

79590

SPAT1359

SPAT

Use of symptom diary

6.8

323.0

1357

1321

ZYC01

NOMESCO Finland

Remote contact by phone

4.5

323.0

2071

3075

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

323.0

2878

6436

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

323.0

12691

57868

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

323.0

11178

47642

-1

NOMESCO Finland

1.9

323.0

11679

45156

M54.5

ICD-10 Finland

Low back pain

1.8

323.0

10998

45009

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.4

323.0

4888

14210

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

323.0

18398

91064

Z3229

NOMESCO Finland

Other healthcare associate professional

2.8

323.0

3702

9099

Z00.0

ICD-10 Finland

General medical examination

3.1

323.0

8679

21173

H02AB06

ATC

prednisolone; systemic

1.7

323.0

16440

75032

L03

ICPC

Low back symptom/complaint

1.9

323.0

7970

29152

Z3226

NOMESCO Finland

Physiotherapist

1.9

323.0

6491

24063

AN2

Balloon angioplasty, including several vessels

4.4

323.0

1509

2278

L28

ICPC

Limited function/disability (L)

2.3

323.0

5975

18255

WZC30

NOMESCO Finland

Teaching

2.7

323.0

5811

15215

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

8.0

323.0

2245

1881

S18

ICPC

Laceration/cut

1.8

323.0

15590

66646

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

323.0

3063

7776

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

116.3

323.0

5447

348

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.2

323.0

5108

16036

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

323.0

6446

21295

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

8.2

323.0

925

737

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

12331

49481

N03AX16

ATC

pregabalin; oral

1.9

323.0

8350

31176

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

9.8

323.0

5050

3715

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.4

323.0

4319

12403

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

5.0

323.0

1434

1877

N06AX11

ATC

mirtazapine; oral

1.7

323.0

10355

44431

N05AH04

ATC

quetiapine; oral

2.0

323.0

5239

17883

SPAT1252

SPAT

Overall medication plan or its review

3.7

323.0

3421

6344

Z51.0

ICD-10 Finland

Radiotherapy session

13.2

323.0

815

402

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

323.0

9761

39327

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

24154

113096

J01DB01

ATC

cefalexin; oral

1.9

323.0

29598

158512

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

323.0

13414

61978

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

323.0

20649

105654

N02AX02

ATC

tramadol; systemic, rectal

1.7

323.0

15499

69063

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

323.0

13110

56984

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

323.0

9880

41473

R53

ICD-10 Finland

Malaise and fatigue

1.9

323.0

6653

24145

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

323.0

10371

44604

SPAT1131

SPAT

Colonoscopy

4.6

323.0

1513

2174

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

323.0

12627

57178

Z3231

NOMESCO Finland

Registered nurse

3.3

323.0

13840

36144

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

323.0

5850

20741

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

323.0

10447

40525

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

323.0

20756

106550

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

323.0

23753

122061

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

323.0

9361

37230

ZX120

NOMESCO Finland

Intravenous

3.0

323.0

4103

9434

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

5.5

323.0

13829

22724

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

323.0

9931

39602

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

323.0

11881

46244

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

323.0

6009

20336

WX110

NOMESCO Finland

Local anesthesy

1.6

323.0

23436

121627

N02BE01

ATC

paracetamol; systemic, rectal

2.3

323.0

31994

168037

N03AX12

ATC

gabapentin; oral

2.0

323.0

5378

18449

HMAK

NOMESCO Finland

3.3

323.0

5235

11284

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

323.0

7370

28329

Z71.9

ICD-10 Finland

Counselling, unspecified

4.8

323.0

2837

3982

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

322.2

4201

13329

SPAT1153

SPAT

Removal of sutures

1.6

321.6

11063

48818

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

319.4

15757

76064

D19

ICPC

Teeth/gum symptom/complaint

1.7

318.1

8203

33337

E66.01

ICD-10 Finland

Obesity due to excess calories

2.8

315.2

2439

5892

TQW80

NOMESCO Finland

Local dermatologic skincare

4.7

314.8

1242

1740

C03CA01

ATC

furosemide; systemic

1.7

312.9

9820

42201

UJF32

NOMESCO Finland

Coloscopy

1.7

307.3

8812

36885

N05BA04

ATC

oxazepam; oral

1.7

305.3

7689

30966

SPAT1310

SPAT

Counselling related to known health issue

1.6

303.9

10389

45617

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

41.9

303.1

442

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

299.6

5762

21235

ZY010

NOMESCO Finland

Hospital outpatient

3.5

299.0

1646

3129

B01AB05

ATC

enoxaparin; parenteral

1.6

298.0

10087

44125

K02.1

ICD-10 Finland

Caries of dentine

1.5

297.0

18438

93212

R1250

NOMESCO Finland

Evaluation of functional capability

5.5

295.0

1006

1193

SPAT1325

SPAT

Vaccination

1.6

294.0

11293

50998

DFF00

NOMESCO Finland

Pure tone audiometry

2.3

291.1

3256

9600

DFF15

NOMESCO Finland

Speech audiometry

3.2

288.7

1779

3684

A98

ICPC

Health maint/preventive medicine

1.9

286.1

35057

207932

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

285.4

6373

24647

R51.80

ICD-10 Finland

Headache

2.0

283.1

4247

14234

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.5

281.7

2529

6651

R42

ICD-10 Finland

Dizziness and giddiness

1.7

278.0

6972

27928

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.5

277.0

1119

1605

L17

ICPC

Foot/toe symptom/complaint

1.7

276.4

7979

33291

SPAT1254

SPAT

Administration of medicine

1.9

275.4

4949

17752

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

275.0

15483

76117

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

274.4

4863

17356

R05

ICPC

Cough

1.7

274.1

6785

27058

N05CF01

ATC

zopiclone; oral

1.6

274.0

10611

47824

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

272.6

3478

10879

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

12.8

272.1

558

282

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

270.4

2913

8418

E66.8

ICD-10 Finland

Other obesity

3.2

270.4

1674

3476

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

267.1

2620

7219

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

265.9

5603

21208

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

263.9

8015

33848

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

263.4

17058

86120

SPAT1263

SPAT

Sampling

1.5

263.0

13640

65650

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

4.2

261.4

1140

1765

A02BC05

ATC

esomeprazole; systemic

1.5

261.0

13246

63417

R83

ICPC

Respiratory infection other

1.7

259.3

6582

26387

N30.0

ICD-10 Finland

Acute cystitis

2.0

258.3

3752

12383

N06AX21

ATC

duloxetine; oral

2.1

258.2

3316

10388

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

257.1

3569

11561

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

255.1

8976

39349

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

254.5

4868

17810

PLAK1

NOMESCO Finland

10.5

254.2

570

350

M25.5

ICD-10 Finland

Pain in joint

1.6

252.5

8572

37217

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

252.2

2339

6249

R4190

NOMESCO Finland

Nutritional therapy

3.7

252.2

1277

2263

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

249.1

5174

19449

R50.9

ICD-10 Finland

Fever, unspecified

1.9

248.8

4616

16696

R5120

NOMESCO Finland

Preparation of an aid

4.0

247.6

1137

1847

L15

ICPC

Knee symptom/complaint

1.7

245.8

6462

26124

R60.0

ICD-10 Finland

Localized oedema

2.0

245.5

3642

12106

N06AX16

ATC

venlafaxine; oral

2.0

244.0

3954

13604

KHV

NOMESCO Finland

17.5

243.8

443

163

XG474

NOMESCO Finland

Exhalation nntrogen oxide

4.2

241.7

1050

1618

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

241.2

4090

14309

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

241.1

5205

19796

R02

ICPC

Shortness of breath/dyspnoea

2.0

240.3

3846

13165

L01

ICPC

Neck symptom/complaint

1.9

239.8

3981

13816

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

235.6

4055

14255

RD210

NOMESCO Finland

5.7

233.7

770

874

G47.3

ICD-10 Finland

Sleep apnoea

1.6

231.8

7620

32688

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

231.4

7877

34092

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

5.0

230.7

847

1094

J01MA02

ATC

ciprofloxacin; systemic

1.5

229.7

13025

63361

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

228.4

2071

5456

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

227.8

18217

94821

XQ848

NOMESCO Finland

Dermatological photography

3.8

227.1

1104

1887

EBA00

NOMESCO Finland

Extraction of tooth

1.5

223.7

10580

49433

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

222.6

3689

12771

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

221.4

5631

22464

SPAT1301

SPAT

No procedures

1.5

221.0

10100

46807

A46

ICD-10 Finland

Erysipelas

1.8

220.5

4916

18841

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

218.3

8422

37509

Z00.8

ICD-10 Finland

Other general examinations

2.3

216.9

2327

6685

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

216.4

4971

19220

P01AB01

ATC

metronidazole; oral, rectal

1.5

216.2

11522

55141

J01AA02

ATC

doxycycline; systemic

1.4

215.8

26495

148826

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

215.5

9692

44703

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

215.4

2183

6096

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

215.2

2092

5717

J01FF01

ATC

clindamycin; systemic

1.5

214.5

8784

39648

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.7

214.0

1731

4271

J01CA04

ATC

amoxicillin; systemic

1.4

213.7

27129

153203

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.2

212.7

2585

7872

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

210.1

13730

68359

R21

ICPC

Throat symptom/complaint

1.7

209.5

4933

19200

PLAK2

NOMESCO Finland

12.9

208.7

426

213

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

207.6

5669

23039

SPAT1262

SPAT

Handing over of treatment supplies

1.6

206.9

6147

25569

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

204.7

2509

7665

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

204.2

7824

34697

ZXE00

NOMESCO Finland

One hour or less

1.4

203.8

12137

59234

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.2

203.1

1229

2500

RF210

NOMESCO Finland

3.5

202.7

1072

1966

Z2445

NOMESCO Finland

Psychologist

3.1

202.5

1263

2628

C08CA01

ATC

amlodipine; oral

1.4

200.9

12044

58811

RF120

NOMESCO Finland

6.9

200.8

573

534

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

200.2

7643

33842

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

200.1

6046

25234

E0000UV

ATC

1.4

199.9

11945

58274

T90

ICPC

Diabetes non-insulin dependent

1.5

198.0

7751

34506

L13

ICPC

Hip symptom/complaint

1.7

197.8

4692

18275

Z2221

NOMESCO Finland

Medical doctor

1.5

196.4

8354

37898

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

194.5

7992

35961

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

193.9

14448

73392

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

193.4

11545

56216

J01MA12

ATC

levofloxacin; systemic

1.6

193.4

6053

25474

XKD00

NOMESCO Finland

Uroflowmetry

1.6

192.6

5839

24365

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

191.3

6067

25612

AN1

Coronary angiography

1.8

190.9

4215

16044

N05BA01

ATC

diazepam; systemic, rectal

1.8

190.7

4195

15946

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

190.6

4344

16699

L08

ICPC

Shoulder symptom/complaint

1.6

190.5

5900

24747

N06AB10

ATC

escitalopram; oral

1.6

189.8

5397

22125

ZXA05

NOMESCO Finland

Left side

1.5

189.4

8396

38390

XX1AD

NOMESCO Finland

Other CT-examination

14.4

189.0

368

164

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

188.7

6611

28608

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

188.4

3776

13925

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

187.5

2998

10202

R74

ICPC

Upper respiratory infection acute

1.5

187.2

7279

32289

R05

ICD-10 Finland

Cough

1.6

187.1

5761

24116

TUPEI

NOMESCO Finland

3.0

186.7

1241

2698

SPAT1229

SPAT

Assessment of need for aid

2.0

186.4

2600

8384

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

185.3

12862

64318

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

184.9

7266

32296

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

184.6

5989

25403

U02

ICPC

Urinary frequency/urgency

1.9

184.6

3399

12175

SPAT1360

SPAT

Extensive global examination

2.1

183.6

2493

7946

R5599

NOMESCO Finland

Other rehabilitation service

3.4

183.2

1004

1894

Z01.2

ICD-10 Finland

Dental examination

1.4

183.0

12040

59569

M79.1

ICD-10 Finland

Myalgia

1.8

182.5

3547

12940

WX290

NOMESCO Finland

Other blockade of nerve

1.4

182.2

13120

65994

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

178.6

6585

28799

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.1

178.3

2427

7741

N06AB04

ATC

citalopram; systemic

1.6

178.2

6181

26634

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

177.5

1750

4804

M03BX02

ATC

tizanidine; oral

1.4

177.4

19762

107005

J45.8

ICD-10 Finland

Mixed asthma

3.2

177.1

1071

2178

H13

ICPC

Plugged feeling ear

1.6

176.9

5749

24365

R06AE07

ATC

cetirizine; oral

1.4

176.7

12787

64272

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

176.7

11504

56710

UKC02

NOMESCO Finland

Cystoscopy

1.6

176.0

5456

22840

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

175.9

4745

19128

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

173.6

1773

4956

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

173.6

2057

6175

SPAT1283

SPAT

Restricted health certificate

1.7

173.4

4038

15590

R52.2

ICD-10 Finland

Other chronic pain

3.1

173.4

1101

2318

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

172.7

3781

14320

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

172.6

12165

60780

SPAT1211

SPAT

Application of soft bandage

1.9

172.1

2824

9691

B01AC04

ATC

clopidogrel; oral

1.6

171.7

5320

22253

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

171.3

7426

33665

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

170.9

3197

11498

J02AC01

ATC

fluconazole; systemic

1.4

170.5

9646

46214

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

170.4

5146

21375

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.8

170.4

1267

2963

P01

ICPC

Feeling anxious/nervous/tense

2.1

169.5

2099

6425

Z2446

NOMESCO Finland

Social worker

2.2

168.4

2034

6156

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.3

168.3

1768

5010

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.5

168.3

7714

35374

R52.9

ICD-10 Finland

Pain, unspecified

2.0

167.7

2529

8400

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

167.6

5472

23183

ZXA00

NOMESCO Finland

Right side

1.5

166.7

8803

41563

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

165.6

1903

5627

B01AF01

ATC

rivaroxaban; oral

1.7

165.5

3834

14766

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

165.1

7388

33682

A28

ICPC

Limited function/disability NOS

1.6

164.5

4575

18572

C10AA01

ATC

simvastatin; oral

1.4

164.5

14705

76385

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.3

164.4

937

1822

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

164.3

15798

83051

J01CA08

ATC

pivmecillinam; oral

1.5

164.1

8535

40152

R11

ICD-10 Finland

Nausea and vomiting

2.1

163.9

2256

7221

N06AA09

ATC

amitriptyline; systemic

1.9

162.3

2985

10661

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.4

161.4

891

1690

C08CA13

ATC

lercanidipine; oral

1.7

161.1

4223

16854

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

161.1

4250

16992

S29

ICPC

Skin symptom/complaint other

1.6

160.8

5010

20951

KMAK

NOMESCO Finland

1.4

159.1

15746

83009

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

158.6

6651

29856

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

158.5

1070

2349

G44.2

ICD-10 Finland

Tension-type headache

1.8

158.1

3376

12665

R13

ICD-10 Finland

Dysphagia

2.1

157.9

2049

6395

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

157.6

2544

8665

TQW99

NOMESCO Finland

Other minor procedure on skin

2.3

157.3

1664

4728

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

157.3

6000

26354

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

156.8

6289

27941

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

156.7

3138

11527

SPAT1097

SPAT

Recording of ECG

1.6

155.2

4708

19534

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

154.8

13296

68386

N06AB06

ATC

sertraline; oral

1.8

154.6

2851

10183

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

154.0

9469

45910

A04

ICPC

Weakness/tiredness general

1.7

153.4

3554

13668

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

152.6

3357

12703

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

152.6

4093

16422

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

152.6

1302

3303

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

152.0

2805

10020

M01AH05

ATC

etoricoxib; oral

1.3

151.6

18866

102792

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

151.2

3156

11745

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.3

150.8

1554

4357

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

150.7

2218

7287

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.2

150.2

1722

5081

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

148.5

4201

17096

P03

ICPC

Feeling depressed

2.1

148.2

2023

6445

SPAT1059

SPAT

Spirometry at the office

2.2

147.1

1728

5157

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

146.9

2815

10179

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

5.9

146.3

467

509

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

144.3

3069

11481

A06AD11

ATC

lactulose; oral

1.6

143.4

4322

17874

RS221

NOMESCO Finland

4.4

143.4

587

852

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

143.1

3259

12453

L02

ICPC

Back symptom/complaint

1.9

142.7

2413

8351

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.4

142.4

1350

3624

M48.0

ICD-10 Finland

Spinal stenosis

1.7

142.0

3788

15155

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

141.0

4053

16546

B01AA03

ATC

warfarin; systemic

1.5

140.6

6498

29687

K30

ICD-10 Finland

Functional dyspepsia

1.8

140.3

2879

10642

R01AD09

ATC

mometasone; nasal

1.3

140.2

12991

67323

D11

ICPC

Diarrhoea

1.8

140.2

2842

10466

SPAT1240

SPAT

Therapeutic discussion

1.9

140.2

2517

8896

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

140.0

2130

7082

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

140.0

2256

7667

A02BC01

ATC

omeprazole; systemic

1.4

139.6

8314

39933

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

138.6

1738

5336

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

138.3

2229

7575

S21

ICPC

Skin texture symptom/complaint

1.7

138.2

3619

14394

XF404

NOMESCO Finland

Ambulatory ECG

1.8

138.0

2954

11066

A10AE04

ATC

insulin glargine; parenteral

1.7

137.5

3125

11925

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

137.4

6650

30653

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

137.1

11777

60236

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

137.1

5394

23779

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.2

136.8

594

914

R07.3

ICD-10 Finland

Other chest pain

1.8

136.8

2837

10521

H03AA01

ATC

levothyroxine sodium; systemic

1.5

136.5

6030

27264

D01

ICPC

Abdominal pain/cramps general

1.8

136.2

2695

9841

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

136.1

1690

5167

A03

ICPC

Fever

1.6

135.6

4131

17109

207

Kela drug reimbursment

Chronic arrhythmias

1.6

135.2

4589

19531

A01

ICPC

Pain general/multiple sites

1.9

134.9

2183

7428

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

134.1

8767

42772

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.9

133.3

946

2145

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

132.8

7886

37794

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

132.3

1986

6565

R03DC03

ATC

montelukast; oral

1.6

132.3

4280

17993

N05AH03

ATC

olanzapine; systemic

2.1

132.3

1699

5269

R00.2

ICD-10 Finland

Palpitations

2.0

132.3

1833

5869

RF212

NOMESCO Finland

23.7

132.0

218

K78

ICPC

Atrial fibrillation/flutter

1.8

131.6

2490

8951

U01

ICPC

Dysuria/painful urination

2.1

131.3

1719

5374

R2110

NOMESCO Finland

Giving the first information

2.1

131.2

1716

5362

L12

ICPC

Hand/finger symptom/complaint

1.6

131.0

3915

16126

RJ190

NOMESCO Finland

51.3

131.0

184

PLAK0

NOMESCO Finland

8.7

130.8

322

237

TK800

NOMESCO Finland

Hemodialysis

3.0

130.7

844

1795

N03AX09

ATC

lamotrigine; oral

2.5

130.7

1175

3065

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.8

130.5

979

2299

L29

ICPC

Musculoskeletal sympt/complt other

1.9

130.3

2123

7237

R01AD12

ATC

fluticasone furoate; nasal

1.4

129.9

7890

37946

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

129.8

3099

11990

ZXA10

NOMESCO Finland

Bilateral

1.5

129.2

5536

24833

B01AB10

ATC

tinzaparin; parenteral

1.9

129.1

2051

6926

A11CC03

ATC

alfacalcidol; systemic

3.0

129.1

848

1825

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

128.4

10159

51133

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

128.3

1495

4439

H02

ICPC

Hearing complaint

1.6

128.3

3636

14764

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

127.8

1863

6085

S97

ICPC

Chronic ulcer skin

2.1

127.7

1732

5495

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

127.7

946

2203

SPAT1281

SPAT

Other administrative function

1.9

127.5

2302

8143

H01

ICPC

Ear pain/earache

1.8

127.4

2644

9795

SPAT1098

SPAT

Exercise ECG

3.1

127.3

783

1610

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

126.7

969

2302

ZX080

NOMESCO Finland

Image guided radiotherapy

3.5

126.6

687

1285

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

126.0

4371

18676

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

125.1

902

2066

SPAT1255

SPAT

Intravenous administration of medicine

1.9

124.9

2049

7002

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.6

124.5

641

1149

SPAT1260

SPAT

Consultation of another employee

1.5

124.3

5143

22877

N06AB03

ATC

fluoxetine; oral

1.7

124.1

3326

13291

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

124.0

2162

7552

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

123.8

2267

8056

C10AA05

ATC

atorvastatin; oral

1.3

123.7

12583

65783

N03AE01

ATC

clonazepam; systemic

2.0

123.4

1718

5507

Z71.0

ICD-10 Finland

Person consulting on behalf of another person

26.9

123.4

197

G04BD12

ATC

mirabegron; oral

1.7

122.9

2964

11491

R33

ICD-10 Finland

Retention of urine

1.8

122.1

2481

9125

M10.9

ICD-10 Finland

Gout, unspecified

1.9

122.1

2184

7697

R31

ICD-10 Finland

Unspecified haematuria

1.7

121.7

3251

12978

C07AA05

ATC

propranolol; systemic

1.5

121.5

5062

22536

R03BB04

ATC

tiotropium bromide; inhalant

1.7

121.3

3069

12063

J01EA01

ATC

trimethoprim; systemic

1.4

121.3

6129

28407

ITSEH

NOMESCO Finland

11.0

120.0

262

153

Z73.6

ICD-10 Finland

Limitation of activities due to disability

61.8

120.0

164

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

120.0

10371

52818

N05BA12

ATC

alprazolam; oral

1.7

120.0

2873

11114

R96

ICPC

Asthma

1.8

119.6

2391

8745

WX002

NOMESCO Finland

Sedation and analgesia

1.5

119.5

5957

27524

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

118.4

1165

3187

M01AE02

ATC

naproxen; oral, rectal

1.3

117.3

17171

94272

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

117.3

4066

17345

N01

ICPC

Headache

1.8

117.3

2200

7876

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.3

117.2

1210

3391

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

117.1

2138

7583

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.4

117.1

401

478

M54.2

ICD-10 Finland

Cervicalgia

1.9

117.0

1947

6682

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

117.0

1978

6828

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

116.8

3898

16476

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

2.8

116.8

850

1958

ZXC50

NOMESCO Finland

Cryotherapy

2.6

116.7

997

2527

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.0

116.4

425

546

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.1

115.8

1417

4300

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.9

115.6

2066

7275

J01FA10

ATC

azithromycin; systemic

1.3

115.3

17154

94299

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.7

115.2

2509

9426

M01AB05

ATC

diclofenac; systemic, rectal

1.3

114.4

21669

122934

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.6

113.8

581

1034

A02BA02

ATC

ranitidine; systemic

1.4

113.8

5899

27434

S06.0

ICD-10 Finland

Concussion

1.7

113.7

2940

11619

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

113.7

2847

11150

P06

ICPC

Sleep disturbance

1.7

113.5

2586

9850

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

113.3

3055

12213

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

112.9

1917

6626

XF402

NOMESCO Finland

ECG with work load test

1.6

112.7

3478

14406

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

112.6

1826

6208

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

112.2

6612

31496

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

111.7

1813

6163

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.6

111.5

567

1006

WZA90

NOMESCO Finland

Other doctors statement

1.4

110.7

6524

31068

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

110.6

1607

5236

A02BC03

ATC

lansoprazole; oral

1.4

110.6

8834

44311

N17

ICPC

Vertigo/dizziness

1.6

110.2

2984

11941

Z50.1

ICD-10 Finland

Other physical therapy

2.0

110.1

1683

5595

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

108.9

1116

3114

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

108.7

3881

16651

L16

ICPC

Ankle symptom/complaint

1.7

108.6

2664

10364

R01AD08

ATC

fluticasone; nasal

1.4

108.4

7948

39293

X58

ICD-10 Finland

Exposure to other specified factors

1.5

108.3

4123

17953

A12AA04

ATC

calcium carbonate; oral

3.4

108.3

599

1138

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.1

108.1

475

740

N06AX12

ATC

bupropion; oral

2.1

107.8

1443

4548

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

107.7

22121

126303

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

107.6

1358

4174

XQ800

NOMESCO Finland

Prick test

1.9

107.5

1769

6043

WW200

NOMESCO Finland

Immunization

2.5

107.1

922

2346

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

107.1

1753

5976

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

107.0

2990

12062

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

106.6

2005

7178

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

106.5

1237

3665

N03AG01

ATC

valproic acid; systemic, rectal

1.9

106.5

1660

5559

B01AF02

ATC

apixaban; oral

1.6

106.3

2915

11696

U71

ICPC

Cystitis/urinary infection other

2.1

106.3

1354

4177

D07AC13

ATC

mometasone; topical

1.4

105.9

8483

42513

S10

ICPC

Boil/carbuncle

2.0

105.9

1561

5115

J01MA14

ATC

moxifloxacin; systemic

1.7

105.8

2620

10216

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

105.7

7028

34154

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

105.2

1464

4687

RP210

NOMESCO Finland

49.9

105.0

148

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

104.9

5598

26134

RJ410

NOMESCO Finland

11.5

104.6

223

124

B03XA02

ATC

darbepoetin alfa; parenteral

3.1

104.2

658

1379

Z94.0

ICD-10 Finland

Kidney transplant status

4.1

103.9

462

728

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

103.7

3050

12463

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

103.7

1834

6426

R01AD01

ATC

beclometasone; nasal

1.5

103.7

4248

18786

ZX112

NOMESCO Finland

Subcutaneous

2.9

103.4

718

1605

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

103.2

4206

18577

N07BB01

ATC

disulfiram; oral

2.0

103.2

1436

4597

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

102.9

1030

2839

J01DA01

ATC

[U] cefalexin; systemic

1.3

102.6

19769

111617

R55

ICD-10 Finland

Syncope and collapse

1.6

102.4

3150

13020

K80

ICPC

Cardiac arrhythmia NOS

1.8

102.4

2029

7387

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

101.2

4773

21733

M04AA01

ATC

allopurinol; systemic

1.5

101.0

4106

18122

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

100.9

2159

8054

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

100.8

2377

9134

U07

ICPC

Urine symptom/complaint other

2.0

100.7

1550

5162

ZX114

NOMESCO Finland

Intramuscular

3.7

100.7

502

876

127

Kela drug reimbursment

Transplant complication

3.3

100.3

574

1119

L04AA06

ATC

mycophenolic acid; systemic

3.2

99.6

606

1236

Z08

ICPC

Social welfare problem

4.3

99.6

421

632

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.3

99.3

1072

3068

RS340

NOMESCO Finland

21.5

99.3

168

R03BA05

ATC

fluticasone; inhalant

1.4

99.2

4944

22750

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

99.2

1717

5969

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

99.2

749

1766

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.9

98.9

467

778

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

98.8

11542

61004

TFP20

NOMESCO Finland

Cardiodefibrillation

1.7

98.6

2357

9092

M79.7

ICD-10 Finland

Fibromyalgia

2.8

98.5

701

1592

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.4

98.0

550

1057

J01FA06

ATC

roxithromycin; oral

1.3

98.0

11918

63319

ZXD05

NOMESCO Finland

Urgent procedure

1.3

97.9

8739

44431

L14

ICPC

Leg/thigh symptom/complaint

1.8

97.9

2040

7545

WX402

NOMESCO Finland

General anaesthesia

1.5

97.9

4575

20780

SPAT1234

SPAT

Support of social functional capacity

2.0

97.8

1473

4863

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

97.5

3123

13031

N05CF02

ATC

zolpidem; oral

1.4

97.4

4793

21994

RF122

NOMESCO Finland

18.0

97.2

174

P74

ICPC

Anxiety disorder/anxiety state

2.7

97.2

751

1796

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.6

97.1

795

1966

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

97.0

1333

4245

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.0

96.9

1335

4255

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

96.6

895

2371

A10BA02

ATC

metformin; oral

1.3

96.2

8601

43721

N05AX12

ATC

aripiprazole; systemic

2.4

96.2

906

2420

RJ421

NOMESCO Finland

9.8

96.1

221

144

K08.3

ICD-10 Finland

Retained dental root

1.7

95.5

2126

8026

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.6

95.3

373

518

R07

ICPC

Sneezing/nasal congestion

2.0

95.0

1412

4639

D07AC01

ATC

betamethasone; topical

1.3

94.8

10105

52664

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

94.4

1357

4400

C03DA01

ATC

spironolactone; oral

1.6

94.3

3125

13143

R03BA01

ATC

beclometasone; inhalant

1.5

94.3

3877

17135

R35

ICD-10 Finland

Polyuria

1.8

94.0

1928

7094

XA402

NOMESCO Finland

ENMG

2.6

94.0

789

1980

Z72.1

ICD-10 Finland

Alcohol use

5.3

93.9

325

393

UJD02

NOMESCO Finland

Gastroscopy

2.0

93.9

1444

4805

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.6

93.6

3060

12827

K05

ICPC

Irregular heartbeat other

2.4

93.4

917

2502

K99

ICPC

Cardiovascular disease other

2.4

93.3

874

2329

A10AE05

ATC

insulin detemir; parenteral

1.8

92.9

1680

5928

K05.30

ICD-10 Finland

Periodontitis complex

1.5

92.9

3596

15680

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

92.8

1663

5851

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

92.7

1345

4375

M01AC06

ATC

meloxicam; systemic, rectal

1.3

92.6

10856

57280

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

91.6

2665

10844

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

91.5

973

2763

R12

ICD-10 Finland

Heartburn

1.8

91.5

1843

6742

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

91.3

2991

12539

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

91.3

1935

7191

SPAT1043

SPAT

Audiometry

1.6

90.7

3007

12642

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.5

90.7

482

888

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

90.6

2034

7695

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

90.3

2161

8334

P76

ICPC

Depressive disorder

2.0

90.2

1318

4299

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

3.6

90.1

456

807

R4120

NOMESCO Finland

Occupational therapy

1.8

89.8

1772

6435

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

89.8

3631

15976

P29

ICPC

Psychological sympt/compl other

2.0

89.8

1220

3865

T82

ICPC

Obesity

2.4

89.5

878

2395

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

89.4

952

2707

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

89.1

2472

9931

ZYC03

NOMESCO Finland

Remote contact, text-based

5.6

89.0

295

339

R5110

SPAT

2.6

88.8

748

1881

C10AA07

ATC

rosuvastatin; oral

1.3

88.7

7368

36960

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.2

88.5

377

571

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

88.0

836

2243

H02AB07

ATC

prednisone; oral

1.5

87.7

3957

17813

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

87.7

1839

6812

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

87.5

6547

32297

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

87.5

2423

9726

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

87.5

5197

24659

N05CD07

ATC

temazepam; oral

1.5

87.5

3517

15451

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

87.3

1965

7436

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

87.3

1568

5518

H29

ICPC

Ear symptom/complaint other

1.6

86.9

2719

11265

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

86.9

1298

4269

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.5

86.9

745

1892

RJ411

NOMESCO Finland

6.7

86.9

251

240

J05AB01

ATC

aciclovir; systemic

1.4

86.8

5425

25968

A29

ICPC

General symptom/complaint other

1.5

85.7

3023

12892

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

85.7

1562

5525

C09AA05

ATC

ramipril; oral

1.3

85.1

7713

39161

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

85.1

1849

6924

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

85.0

1414

4841

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.5

84.9

3277

14261

K86

ICPC

Hypertension uncomplicated

1.5

84.9

3305

14414

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

84.5

2701

11244

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

84.5

1616

5809

D06

ICPC

Abdominal pain localized other

1.7

84.5

1870

7040

RD112

NOMESCO Finland

18.7

84.5

149

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.6

84.3

2517

10303

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

84.0

2537

10412

J37.0

ICD-10 Finland

Chronic laryngitis

2.3

84.0

870

2440

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

83.9

2624

10866

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.5

83.8

3165

13707

WX308

NOMESCO Finland

Sacral anesthesy

9.7

83.3

193

128

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.4

83.1

454

855

DAX08

NOMESCO Finland

Fitting of hearing aid

2.0

83.0

1235

4057

T89

ICPC

Diabetes insulin dependent

2.0

82.9

1137

3616

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

6.0

82.9

259

276

RF430

NOMESCO Finland

17.9

82.7

148

U05

ICPC

Urination problems other

1.9

82.6

1278

4261

R4110

SPAT

2.4

82.6

787

2115

ZY000

NOMESCO Finland

Hospital inpatient

4.3

82.5

349

525

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

82.3

30445

183281

B02.9

ICD-10 Finland

Zoster without complication

1.8

82.2

1551

5548

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

82.2

1689

6213

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

82.1

2249

8999

U04

ICPC

Incontinence urine

2.0

81.9

1156

3718

C09CA01

ATC

losartan; oral

1.3

81.8

7283

36846

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

81.6

2102

8270

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.7

81.6

648

1574

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.9

81.6

567

1269

E000001

ATC

1.4

81.4

5468

26469

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.7

81.3

398

685

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

81.3

1956

7546

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

81.2

1715

6362

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.3

81.2

878

2513

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.9

81.2

1262

4215

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

81.1

3435

15247

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

80.9

1163

3769

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.2

80.9

915

2676

P15

ICPC

Chronic alcohol abuse

2.3

80.7

863

2459

XG466

NOMESCO Finland

Sleep oxymetry

2.1

80.4

1042

3236

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.8

80.4

383

644

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.9

80.1

371

608

Z50.5

ICD-10 Finland

Speech therapy

3.8

79.9

387

660

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

79.8

2845

12151

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

79.8

1444

5092

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

79.8

2614

10946

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

79.8

2356

9611

SPAT1053

SPAT

Memory test

1.4

79.7

4191

19416

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

79.7

3110

13559

H92.0

ICD-10 Finland

Otalgia

2.0

79.5

1170

3826

SPAT1236

SPAT

Informing family of child’s disability

2.5

79.2

693

1780

M54.8

ICD-10 Finland

Other dorsalgia

2.1

78.8

995

3056

H02AB04

ATC

methylprednisolone; systemic

1.4

78.7

3932

18035

WW200

SPAT

0.6

78.4

1278

13469

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.1

78.2

493

1033

J01CF05

ATC

flucloxacillin; systemic

2.0

78.1

1098

3527

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

77.7

4062

18788

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

77.7

2097

8352

S04

ICPC

Lump/swelling localized

1.6

77.7

2303

9402

RF421

NOMESCO Finland

5.7

77.6

251

280

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

77.6

528

1166

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.4

77.5

427

810

G04BD08

ATC

solifenacin; oral

1.7

77.5

1836

7051

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.8

77.4

565

1305

PLAK3

NOMESCO Finland

13.0

77.4

156

K92.1

ICD-10 Finland

Melaena

1.8

76.8

1500

5426

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

76.8

2429

10080

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

76.8

3948

18203

W19

ICD-10 Finland

Unspecified fall

1.5

76.7

2632

11139

A10BH01

ATC

sitagliptin; oral

1.5

76.4

2796

12008

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

15.5

76.1

143

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.2

76.1

325

494

R15

ICD-10 Finland

Faecal incontinence

2.5

76.0

678

1759

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

76.0

6135

30542

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

75.9

2916

12661

RK112

NOMESCO Finland

46.1

75.9

108

G04CA02

ATC

tamsulosin; oral

1.3

75.8

7635

39242

AA1AD

NOMESCO Finland

CT of head and brain

1.3

75.7

6970

35375

R30.0

ICD-10 Finland

Dysuria

2.1

75.7

952

2917

RF220

NOMESCO Finland

3.0

75.5

487

1037

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.5

75.2

404

752

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

75.0

1270

4376

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

74.9

1000

3143

S80.0

ICD-10 Finland

Contusion of knee

1.8

74.8

1575

5837

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.1

74.7

952

2936

A27

ICPC

Fear of other disease NOS

2.0

74.7

1135

3758

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

74.6

2191

8921

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

74.6

1183

3980

I50.0

ICD-10 Finland

Congestive heart failure

1.6

74.5

2029

8099

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

74.5

1100

3603

F34.1

ICD-10 Finland

Dysthymia

2.2

74.2

820

2372

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

74.2

2827

12251

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

74.2

10139

54193

R07.0

ICD-10 Finland

Pain in throat

1.8

74.1

1387

4945

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

73.9

971

3031

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

73.9

784

2225

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.4

73.9

409

779

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

73.8

4694

22476

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

73.7

1233

4229

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.9

73.7

1141

3805

N05AA02

ATC

levomepromazine; systemic

2.0

73.6

1124

3727

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

73.6

2918

12757

WW500

NOMESCO Finland

Blood transfusion

2.0

73.5

1094

3591

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

73.5

8409

43937

Z49.2

ICD-10 Finland

Other dialysis

4.6

73.5

286

396

K08.80

ICD-10 Finland

Toothache NOS

1.7

73.3

1808

7020

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

73.0

1732

6649

R32

ICD-10 Finland

Unspecified urinary incontinence

2.4

72.8

705

1912

Z01.7

ICD-10 Finland

Laboratory examination

1.5

72.8

2889

12628

WX722

NOMESCO Finland

PEEP

1.8

72.8

1446

5258

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.2

72.7

222

230

R04.0

ICD-10 Finland

Epistaxis

1.6

72.6

2069

8356

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

72.6

914

2805

S22.3

ICD-10 Finland

Fracture of rib

1.6

72.4

1920

7606

L86

ICPC

Back syndrome with radiating pain

1.8

72.3

1449

5283

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

72.3

7267

37303

ZX100

NOMESCO Finland

Oral

3.1

72.0

453

949

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

71.9

6683

33933

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

71.8

585

1442

RJ630

NOMESCO Finland

39.5

71.8

105

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.7

71.8

1757

6807

RS222

NOMESCO Finland

3.4

71.6

394

747

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

71.5

927

2878

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

71.4

593

1480

M01AX17

ATC

nimesulide; oral

1.3

71.4

7055

36120

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.9

71.4

496

1111

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

71.3

2954

13033

D10

ICPC

Vomiting

1.9

71.2

1119

3750

N04BC05

ATC

pramipexole; oral

1.6

71.1

1958

7837

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.7

71.1

1662

6355

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

71.0

1855

7320

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

70.9

1551

5814

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

70.9

1491

5520

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

3.9

70.8

329

542

ZZA00

NOMESCO Finland

Split skin graft

2.1

70.7

882

2695

F03

ICPC

Eye discharge

1.8

70.6

1421

5190

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

70.5

1114

3742

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

70.2

1278

4515

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

70.2

2875

12649

RJ511

NOMESCO Finland

17.5

70.1

126

R06AX27

ATC

desloratadine; oral

1.3

70.1

6663

33920

137

Kela drug reimbursment

Uraemia requiring dialysis

3.9

70.0

329

547

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

69.8

893

2757

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

69.7

933

2938

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

69.6

1061

3517

A99

ICPC

Disease/condition unspecnature/site

1.6

69.6

2053

8365

R06.5

ICD-10 Finland

Mouth breathing

1.5

69.5

2589

11155

L04

ICPC

Chest symptom/complaint

1.8

69.5

1451

5361

M01AX05

ATC

glucosamine; oral

1.3

69.4

5621

27950

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.1

69.4

899

2793

C09CA06

ATC

candesartan; oral

1.3

69.3

5964

29923

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

69.1

1951

7861

K04

ICPC

Palpitations/awareness of heart

1.9

68.9

1213

4237

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

68.7

484

1094

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

68.6

5065

24823

Z43.3

ICD-10 Finland

Attention to colostomy

14.2

68.5

133

Z72.0

ICD-10 Finland

Tobacco use

2.7

68.4

535

1289

JN4BD

NOMESCO Finland

Extensive body CT

1.5

68.2

3142

14159

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

67.9

6981

35903

F10.24

ICD-10 Finland

Alcohol depence active use

2.9

67.8

455

996

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.6

67.7

542

1325

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

67.7

862

2657

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

67.6

2798

12334

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

67.6

3029

13574

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

67.5

430

908

V03AE02

ATC

sevelamer; oral

5.2

67.4

235

288

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

67.4

2965

13239

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

67.2

1385

5094

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

67.0

804

2415

K59.0

ICD-10 Finland

Constipation

1.8

67.0

1390

5124

C02AC05

ATC

moxonidine; oral

1.8

66.9

1322

4799

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

66.8

8431

44505

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.7

66.8

516

1235

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.0

66.7

240

305

XCH00

NOMESCO Finland

Eye pressure measurement

1.9

66.7

1126

3873

RS142

NOMESCO Finland

17.4

66.7

120

TGC00

NOMESCO Finland

Bronchial lavation

2.2

66.7

757

2217

K85

ICPC

Elevated blood pressure

1.4

66.6

4044

19181

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.2

66.6

729

2101

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

66.5

1205

4249

B05DA

ATC

Isotonic solutions

4.4

66.5

274

403

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.6

66.2

2039

8396

N06AX26

ATC

vortioxetine; oral

1.8

66.1

1246

4453

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

66.0

2288

9692

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

66.0

2414

10354

A07AA02

ATC

nystatin; oral

1.7

65.9

1631

6337

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.6

65.3

2103

8753

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

65.3

1813

7269

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

65.2

7587

39623

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.0

65.1

939

3045

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.8

65.1

309

519

RS314

NOMESCO Finland

18.4

65.1

115

K29

ICPC

Cardiovascular sympt/complt other

1.8

64.9

1173

4132

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.1

64.9

285

446

A11

ICPC

Chest pain NOS

1.6

64.7

2009

8286

D02

ICPC

Abdominal pain epigastric

1.8

64.6

1292

4707

130

Kela drug reimbursment

Malignant tumour

1.5

64.4

2427

10479

C05AA08

ATC

fluocortolone; rectal, topical

1.4

64.3

3975

18905

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.6

64.2

330

593

N06AB05

ATC

paroxetine; oral

1.7

64.1

1486

5664

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

64.1

961

3164

N18.0

ICD-10 Finland

End-stage renal disease

3.1

64.0

401

838

RF110

NOMESCO Finland

11.2

63.9

137

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.3

63.7

674

1910

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.8

63.7

1168

4135

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

63.6

930

3033

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.8

63.6

1198

4282

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14618

60452

1.48

316.91

1.7

1.6

pmol/l

11907484.3

37217380.9

10.94

12564

50168

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4587

13998

1.93

316.34

10.5

9.3

mmol/l

24.2

24.3

0.92

4384

12975

(3005719) IgG [Mass/volume] in Serum or Plasma

6448

21972

1.74

313.09

2.8

2.6

g/l

10.5

10.6

1.21

6008

20032

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

60967

323026

1.54

312.68

4.9

4.5

mmol/l

2.7

2.8

143.79

57384

299389

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

11059

43297

1.54

309.98

2.3

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10153

39000

1.56

309.50

2.2

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

64590

325183

2.49

307.65

18.8

12.0

mg/l

21.5

23.7

51.62

54538

250796

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

9368

33178

1.70

307.65

3.1

2.7

umol/l

7.6

8.6

4.31

8191

28745

(3009261) Glucose [Presence] in Urine by Test strip

33311

156441

1.40

307.65

4.0

3.4

estimate

0.0

0.87

9996

23619

(3018677) aPTT in Platelet poor plasma by Coagulation assay

11482

44041

1.58

307.65

2.6

2.1

30.4

29.6

24.95

11238

42658

(3006315) Basophils [#/volume] in Blood

37867

154325

1.86

307.65

7.1

5.6

e9/l

0.0

0.69

33201

133366

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

34529

144920

1.70

307.65

4.2

3.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

44014

218990

1.38

307.65

3.6

2.8

u/l

49.1

45.4

12.83

41910

205320

(3021960) Folate [Moles/volume] in Serum or Plasma

17375

64201

1.72

307.65

1.6

1.5

nmol/l

20.5

20.3

1.45

15449

54895

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

13320

52597

1.55

307.65

1.3

iu/ml

39.1

33.8

0.92

3865

16656

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

66336

346759

2.41

307.65

12.5

9.2

u/l

26.4

26.7

2.82

64963

334442

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

13601

49904

1.68

307.65

3.3

2.5

e6/l

1.1

1.2

0.83

7357

28475

(3018095) Leukocytes [#/volume] in Urine

28500

103434

1.95

307.65

4.8

3.3

e6/l

108.9

88.5

2.84

21023

70910

(36304419) Bacteria [Presence] in Urine

21958

77779

1.88

307.65

3.9

2.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12626

49481

1.55

307.65

1.3

1.2

u/ml

13.7

10.7

2.78

5226

19224

(3026782) Osmolality of Urine

18008

53382

2.24

307.65

3.4

2.5

mosm/kgh2o

536.0

557.1

22.27

16036

44746

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

19865

76354

1.67

307.65

3.2

2.9

ng/l

1512.9

1336.4

4.35

17047

64581

(3002179) Metamyelocytes/100 leukocytes in Blood

9433

18917

3.13

307.65

4.9

3.5

0.6

0.7

1.69

1785

4331

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

27407

104729

1.80

307.65

4.2

3.0

e6/l

0.6

0.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

12929

51241

1.54

307.65

1.8

1.7

nmol/l

1134.4

1164.3

2.91

10208

38586

(3018010) Neutrophils/100 leukocytes in Blood

37693

146461

2.00

307.65

7.0

5.6

57.2

56.9

3.57

35746

136908

(3042936) Bacteria identified in Isolate by Culture

11494

40578

1.73

307.65

2.3

1.9

—

(3019069) Monocytes/100 leukocytes in Blood

37438

143561

2.03

307.65

7.5

6.0

8.6

8.5

1.37

35510

134283

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5718

17420

1.95

307.65

4.5

3.7

kpa

5.1

0.03

5243

16156

(40760892) CBC W Ordered Manual Differential panel - Blood

17311

69564

1.55

307.65

5.3

4.1

—

(3028707) Methadone [Presence] in Urine by Screen method

2508

4846

3.02

307.65

2.9

2.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

7637

24205

1.89

307.65

11.1

6.5

mmol/l

9.7

9.5

1.63

7379

22917

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

59276

306829

1.62

307.65

4.6

4.2

mmol/l

5.9

43.31

55481

281421

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

63124

295799

2.98

307.65

17.6

10.9

ml/min/173m2

83.8

83.9

0.47

55969

237766

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

11924

45559

1.59

307.65

2.0

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

7819

20303

2.34

307.65

4.9

3.4

mmol/l

1.2

0.11

7305

17350

(3024731) MCV [Entitic volume]

68874

368487

3.32

307.65

26.6

17.7

90.9

90.6

52.74

68442

363114

(3036481) Cortisol [Moles/volume] in Serum or Plasma

8058

26297

1.84

307.65

2.3

2.2

nmol/l

361.8

378.5

9.76

7562

24121

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

37375

154240

1.81

307.65

6.8

5.8

umol/l

11.0

11.6

11.16

35816

145538

(3048689) Calprotectin [Mass/mass] in Stool

10566

38800

1.65

307.65

2.6

2.4

ug/g

130.9

134.1

0.38

8479

30549

(3012095) Magnesium [Moles/volume] in Serum or Plasma

13232

44982

1.83

307.65

4.2

3.3

mmol/l

0.8

12.12

12521

41793

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

17516

70952

1.54

307.65

1.3

u/ml

1.7

1.8

0.09

5007

18994

(3017181) Myelocytes/100 leukocytes in Blood

10105

21136

3.01

307.65

5.1

3.7

0.8

1.0

5.60

2403

6139

(40768804) Tissue Pathology biopsy report

28950

124027

1.56

307.65

2.2

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

31885

122928

1.87

307.65

2.6

2.2

nmol/l

76.3

817.3

0.50

29605

110653

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

8800

31948

1.65

307.65

4.4

4.2

u/l

241.7

242.9

0.25

8424

30125

(3044640) Blood type and Crossmatch panel - Blood

24091

94704

1.68

307.65

2.8

2.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5608

16686

1.99

307.65

8.8

7.3

mmol/l

24.8

24.7

0.62

5580

16548

(3013707) Erythrocyte sedimentation rate by Westergren method

50572

231068

1.86

307.65

4.7

3.8

mm/h

12.2

11.3

35.93

47968

213622

(3007164) IgA [Mass/volume] in Serum or Plasma

16253

60712

1.68

307.65

1.5

1.4

g/l

2.4

2.3

2.07

9845

37547

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

52901

235668

2.10

307.65

9.0

6.9

u/l

78.9

77.5

7.72

50822

221131

(3013115) Eosinophils [#/volume] in Blood

38814

159757

1.85

307.65

7.5

5.8

e9/l

0.2

1.28

34629

140153

(3021589) Normoblasts [#/volume] in Blood

38849

130583

2.54

307.65

11.5

8.4

e9/l

0.0

0.56

33259

105411

(3020564) Creatinine [Moles/volume] in Serum or Plasma

66601

344413

2.70

307.65

20.8

13.8

umol/l

78.5

76.0

42.40

66561

344247

(3002385) Erythrocyte distribution width [Ratio]

55786

272552

1.78

307.65

22.3

14.5

13.7

13.6

15.94

55289

266230

(3022096) Basophils/100 leukocytes in Blood

36540

137942

2.05

307.65

7.3

5.8

0.7

0.33

34560

128329

(3028626) Oxygen [Partial pressure] in Capillary blood

2815

6347

2.59

307.65

4.4

3.9

kpa

8.5

0.65

2562

5987

(3003458) Phosphate [Moles/volume] in Serum or Plasma

10899

36456

1.83

307.65

8.5

5.3

mmol/l

1.1

1.0

16.86

10343

33826

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

23182

93579

1.61

307.65

3.0

2.4

u/l

57.0

58.7

2.90

21848

86050

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2649

6299

2.45

307.65

3.8

2.8

mmol/l

24.3

24.7

3.06

2195

5667

(3023103) Potassium [Moles/volume] in Serum or Plasma

65157

327213

2.68

307.65

20.6

13.8

mmol/l

4.0

6.44

64200

317330

(40768797) Stomach Pathology biopsy report

11375

38838

1.80

307.65

1.3

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

14439

44764

2.05

307.65

3.5

2.7

e6/l

3.3

2.8

4.84

8199

23560

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

51639

245424

1.73

307.65

4.4

3.8

pmol/l

14.6

14.7

13.54

48394

223052

(3014111) Lactate [Moles/volume] in Serum or Plasma

7374

24250

1.82

307.65

8.4

6.8

mmol/l

1.3

1.4

4.14

7015

23464

(3031040) Bacteria [#/volume] in Urine by Automated count

45547

204117

1.76

307.65

5.3

4.0

e6/l

1370.3

1264.6

0.10

195

3303

(3021440) Promyelocytes/100 leukocytes in Blood

9921

19822

3.15

307.65

5.2

3.7

0.1

0.2

8.71

2336

5592

(3001122) Ferritin [Mass/volume] in Serum or Plasma

33531

138267

1.73

307.65

3.5

2.7

ug/l

116.0

119.8

1.50

31727

128530

(3045716) Anion gap in Serum or Plasma

948

702

7.79

307.65

1.9

3.0

mmol/l

9.4

8.7

2.18

878

337

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

45186

224926

1.40

307.65

3.7

3.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

13519

53626

1.54

307.65

1.8

1.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

36343

144051

1.90

307.65

8.5

6.2

mmol/l

1.2

4.42

32374

120706

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

59297

294530

1.90

307.65

5.3

4.4

mu/l

2.1

0.01

56132

270578

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

28369

119313

1.59

307.65

2.2

1.9

pmol/l

95.4

96.4

2.80

15654

62056

(3007853) Bacteria identified in Skin by Aerobe culture

9748

34991

1.68

307.65

2.0

1.7

—

(3021901) Oxygen saturation in Capillary blood

2113

4379

2.80

307.65

3.4

2.6

—

(3010813) Leukocytes [#/volume] in Blood

68890

368611

3.34

307.65

26.7

17.8

e9/l

6.8

6.7

21.51

67718

357349

(3026008) Bacteria identified in Urine by Culture

23020

85094

1.80

307.65

3.4

2.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

24149

101302

1.54

307.65

3.5

3.1

u/l

32.3

33.2

0.98

23129

95989

(3024354) Oxygen [Partial pressure] in Venous blood

6659

21388

1.86

307.65

4.4

3.3

kpa

4.8

4.6

9.66

6400

20729

(3037522) Nuclear Ab [Titer] in Serum

10972

41874

1.58

307.65

1.4

1.3

titre

508.3

550.7

1.43

2334

8166

(3000850) Epithelial cells [#/volume] in Urine

17636

59269

1.93

307.65

3.2

2.4

e6/l

5.8

5.5

1.39

15489

51557

(3026361) Erythrocytes [#/volume] in Blood

68878

368527

3.33

307.65

26.7

17.7

e12/l

4.5

181.17

67727

357238

(3002582) Erythrocytes [#/volume] in Urine

25653

86034

2.10

307.65

4.1

2.9

e6/l

91.0

87.9

0.09

20214

64755

(3025159) Blasts/100 leukocytes in Blood

9456

18606

3.19

307.65

5.2

3.7

0.1

0.3

1.41

1941

4746

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

16951

66145

1.61

307.65

2.0

1.7

mg/l

1.2

0.21

12858

50071

(3019198) Lymphocytes [#/volume] in Blood

38374

159311

1.81

307.65

7.1

5.6

e9/l

1.9

0.31

34405

140195

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

18747

71540

1.67

307.65

2.7

2.2

—

(3009343) pH of Capillary blood

5601

17256

1.92

307.65

4.5

3.7

7.4

3.70

640

2078

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

25225

109566

1.48

307.65

3.8

3.2

ng/l

101.7

55.3

1.34

17111

69089

(3007461) Platelets [#/volume] in Blood

68857

368098

3.34

307.65

26.7

17.8

e9/l

254.6

252.5

13.48

67750

357978

(3044889) 12 lead EKG panel

44330

214322

1.48

307.65

3.7

3.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6184

20057

1.83

307.65

1.7

1.6

—

(3035941) MCH [Entitic mass]

68877

368436

3.33

307.65

26.6

17.7

30.2

11.35

68448

363078

(3012544) pH of Venous blood

8403

26967

1.88

307.65

5.3

3.8

7.4

1.66

125

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4790

14549

1.94

307.65

3.4

2.5

e6/l

0.3

0.34

4661

14135

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2989

7467

2.34

307.65

1.9

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

18570

79116

1.46

307.65

3.0

2.5

umol/l

3185.7

4489.1

5.13

16316

69090

(3013512) EKG study

19236

81793

1.47

307.65

4.5

3.5

—

(3023368) Bacteria identified in Blood by Culture

20186

76043

1.72

307.65

5.0

3.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

16105

65691

1.51

307.65

2.1

1.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

9929

35084

1.71

307.65

8.2

6.8

mmol/l

104.5

0.58

9850

34201

(3002030) Lymphocytes/100 leukocytes in Blood

38107

148716

2.00

307.65

7.3

5.8

28.1

28.5

8.62

35995

138411

(3037467) Urinalysis macro (dipstick) panel - Urine

47067

216600

1.71

307.65

5.1

3.9

—

(3022145) Colonoscopy Study observation

9019

32718

1.65

307.65

1.4

1.3

—

(3032080) INR in Blood by Coagulation assay

27253

116935

1.53

307.65

9.9

8.0

inr

1.3

1.2

2.99

9896

31314

(3022948) Iron [Moles/volume] in Serum or Plasma

13380

44708

1.87

307.65

3.1

2.3

umol/l

12.9

13.9

1.47

12687

41246

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

21099

87305

1.54

307.65

2.3

2.0

u/l

203.1

215.4

0.78

20190

81682

(3022217) INR in Platelet poor plasma by Coagulation assay

9780

35218

1.68

307.65

22.1

24.0

inr

1.4

1.3

3.61

2462

4128

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

8113

25729

1.90

307.65

2.5

2.3

g/l

0.2

0.28

7617

23908

(3017569) Oxygen content in Arterial blood

834

709

6.77

307.65

1.9

2.4

—

(3002032) Base excess in Venous blood by calculation

7997

25976

1.85

307.65

5.5

3.7

mmol/l

1.8

0.42

6647

21099

(40761511) CBC panel - Blood by Automated count

64957

341990

1.99

307.65

15.8

11.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

8146

25948

1.89

307.65

5.4

3.7

kpa

5.9

5.8

2.61

7893

25206

(3000963) Hemoglobin [Mass/volume] in Blood

68888

368662

3.33

307.65

26.9

17.8

g/l

134.0

136.4

307.65

68449

363349

(3013650) Neutrophils [#/volume] in Blood by Automated count

42417

178343

1.89

307.65

10.7

8.4

e9/l

4.1

1.89

37427

155414

(42870588) Differential panel, method unspecified - Blood

25156

103878

1.59

307.65

7.0

5.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

14493

55431

1.62

307.65

4.2

3.5

ng/l

405.1

536.6

2.17

10261

41524

(3020682) Albumin/Creatinine [Ratio] in Urine

20219

88512

1.42

307.65

4.3

3.9

mg/mmol

12.1

8.8

3.84

14198

55186

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

5167

16171

1.89

307.65

1.6

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

33058

154720

1.41

307.65

5.5

4.5

estimate

0.0

0.70

10210

24397

(40758558) Short blood count panel - Blood

18660

77215

1.51

307.65

7.8

6.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

30769

131961

1.58

307.65

7.6

5.7

mmol/l

1.2

6.29

28655

118999

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

56545

287880

1.59

307.65

6.1

5.2

mmol/mol

40.0

39.2

69.44

53540

267110

(3015377) Calcium [Moles/volume] in Serum or Plasma

23245

98313

1.52

307.65

3.6

3.2

mmol/l

2.4

1.08

20715

85622

(3000991) Gas panel - Venous blood

7330

23555

1.86

307.65

10.4

7.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

20567

82462

1.59

307.65

3.9

2.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

41229

176757

1.79

307.65

5.7

4.4

mmol/l

6.6

6.7

1.02

39224

162907

(3006504) Eosinophils/100 leukocytes in Blood

37345

142647

2.04

307.65

7.2

5.7

2.8

2.9

1.02

35319

132685

(3024561) Albumin [Mass/volume] in Serum or Plasma

30396

127547

1.63

307.65

5.9

4.5

g/l

35.6

35.8

6.61

28800

117883

(3030467) Casts [#/volume] in Urine by Automated count

22982

79147

1.97

307.65

3.9

2.8

e6/l

0.4

3.19

17604

58486

(3035350) Ketones [Presence] in Urine by Test strip

32827

154423

1.39

307.65

3.9

3.4

estimate

0.0

2.93

9991

23731

(3004789) Transferrin [Mass/volume] in Serum or Plasma

12501

40895

1.90

307.65

3.1

2.3

g/l

2.4

0.04

11801

37599

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2192

4439

2.87

307.65

4.9

2.5

—

(3018418) pH of Serum or Plasma

20092

85791

1.47

307.65

5.2

3.8

7.4

45.14

4912

14296

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

11660

37856

1.90

307.65

3.2

2.4

22.1

23.3

14.44

10766

31629

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

8622

26237

1.99

307.65

3.0

2.3

u/l

39.1

47.1

0.84

7516

22354

(3017143) Hepatitis C virus Ab [Presence] in Serum

10405

38148

1.65

307.65

1.8

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

19756

75155

1.69

307.65

5.0

3.7

90.8

0.01

19400

73124

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

4818

13324

2.14

307.65

5.8

4.2

mmol/l

24.1

0.58

4472

11908

(3019550) Sodium [Moles/volume] in Serum or Plasma

65083

326139

2.68

307.65

20.3

13.8

mmol/l

139.5

139.7

102.58

64226

316956

(3009508) Creatinine [Moles/volume] in Urine

21894

92288

1.51

307.65

3.6

3.1

mmol/l

7.5

8.0

2.45

19086

77625

(3001604) Monocytes [#/volume] in Blood

37625

153697

1.84

307.65

7.0

5.6

e9/l

0.6

2.09

33013

132840

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

19841

72561

1.78

307.65

2.5

2.2

mg/l

2.9

0.74

17443

61684

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

5306

16799

1.87

307.65

4.5

3.7

mmol/l

1.7

1.6

1.35

3809

12370

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

60115

317943

1.51

303.69

4.6

4.1

mmol/l

4.6

4.7

149.37

56876

296544

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

57949

304286

1.47

302.08

4.1

3.7

mmol/l

1.3

21.54

54514

280975

(3011288) Drugs identified in Urine by Screen method

3225

8861

2.13

294.70

3.4

2.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

59648

315565

1.49

290.53

4.5

4.0

mmol/l

1.4

1.5

15.99

56359

292881

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3814

11274

1.98

287.13

2.3

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3538

10314

2.01

276.47

2.1

1.7

—

(3012516) Albumin [Mass/volume] in Urine

19011

84379

1.39

272.55

3.6

3.2

mg/l

234.5

463.7

14.24

13490

52367

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4827

15736

1.80

270.14

1.8

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

7556

27954

1.61

266.46

4.1

4.0

ug/l

21.1

26.8

0.55

5959

22298

(3003694) ABO and Rh group [Type] in Blood

20284

91764

1.36

254.83

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

14945

64445

1.41

249.46

1.7

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

6659

24367

1.62

244.12

1.5

1.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

429

296

8.31

243.98

3.7

8.6

71.7

68.5

0.85

386

204

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

649

737

5.06

242.98

2.7

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

5007

17020

1.73

242.18

1.9

1.8

g/l

1.3

0.92

4653

15472

(3019230) Fractional oxyhemoglobin in Venous blood

1859

4388

2.45

239.55

4.0

3.2

64.2

65.1

0.90

1851

4375

(4198724)

771

1058

4.19

233.95

2.7

1.6

—

(3000494) Fungus identified in Specimen by Culture

8799

34640

1.51

233.88

1.6

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

6230

22655

1.62

233.61

2.9

2.6

e9/l

69.4

0.02

4643

17030

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

9894

39979

1.48

231.57

2.0

1.7

1.5

1.4

42.83

8759

35615

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5808

20815

1.64

230.50

5.0

3.7

ng/l

103.4

86.5

21.19

5070

18057

(3052851) Hemolysis interference index of Serum or Plasma

2883

8370

2.00

226.87

3.3

3.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

441

351

7.20

226.27

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

886

1403

3.63

223.66

1.8

1.5

—

(3022313) Gas panel - Capillary blood

3945

12799

1.80

222.79

4.6

4.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3422

10646

1.87

220.48

2.6

1.9

—

(3024928) Oxygen saturation in Venous blood

2110

5481

2.23

219.93

3.9

3.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

8033

31417

1.52

219.03

2.7

2.6

1.8

1.7

3.69

7314

27656

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12233

51969

1.41

217.94

3.1

3.0

mmol/l

2.4

3.65

10707

45208

(3023511) Choriogonadotropin [Units/volume] in Urine

2321

6349

2.12

213.30

1.4

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2893

8611

1.95

212.11

2.0

1.7

—

(3002256) Pathology report gross observation

9546

38956

1.46

210.51

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

2125

5675

2.17

207.17

3.8

3.0

mmol/l

1.5

1.6

1.81

2086

5561

(3044242) Glucose [Moles/volume] in Arterial blood

679

935

4.17

205.19

1.8

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

5951

22211

1.58

198.66

2.5

g/l

66.3

66.6

2.82

5515

20108

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3140

9918

1.84

192.46

2.1

2.3

g/l

7.3

7.4

0.34

2406

7316

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3137

9907

1.84

192.37

2.1

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3130

9891

1.84

191.55

2.1

2.3

g/l

3.8

1.27

2316

6959

(3016879) Cocaine [Presence] in Urine

3884

13140

1.72

189.39

2.6

1.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

703

1062

3.80

189.06

41.2

33.9

ug/l

7.4

7.3

0.48

646

969

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2620

7848

1.94

188.25

1.4

ug/g

280.7

276.0

0.48

1526

4515

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7854

31484

1.47

187.81

1.8

1.7

—

(1616796) Gas panel - Central venous blood

2060

5662

2.11

186.75

5.0

3.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5187

19076

1.59

183.54

3.1

3.4

pmol/l

4.4

4.5

7.20

4682

16991

(3000764) Benzodiazepines [Presence] in Urine

4092

14221

1.68

180.75

2.6

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3638

12317

1.72

176.57

1.9

1.7

g/l

1.5

0.00

3171

10439

(3028300) Cannabinoids [Presence] in Urine

4109

14391

1.67

176.16

2.6

1.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1074

2240

2.76

175.69

3.8

u/ml

39.9

51.3

1.07

1067

2207

(3027008) Opiates [Presence] in Urine

4102

14370

1.67

175.69

2.6

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2826

8892

1.85

174.98

3.1

2.7

g/l

3.6

0.10

2706

8465

(3036489) Thrombin time

3328

11026

1.76

174.11

2.5

2.1

21.6

0.16

2951

9481

(3019225) pH of Specimen

6992

27827

1.48

172.26

5.1

3.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3113

10151

1.78

171.76

1.4

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

5350

20131

1.56

171.14

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

4031

14151

1.66

171.13

2.5

1.7

—

(4035726)

6380

24982

1.50

170.01

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2719

8580

1.84

166.70

3.0

2.6

188.3

184.0

1.54

2610

8090

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2459

7522

1.89

165.81

1.4

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4779

40533

0.65

165.67

6.2

6.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7765

31770

1.44

165.45

1.9

1.7

—

(3037121) Protein [Mass/volume] in Urine

2955

9611

1.79

164.29

3.4

3.3

g/l

0.3

0.88

1311

4437

(3025941) Bacteria identified in Stool by Culture

4831

17929

1.58

163.72

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2886

9389

1.78

160.24

2.1

2.3

g/l

3.0

3.1

4.88

2357

7166

(3029937) Albumin [Presence] in Urine by Test strip

17547

82050

1.29

157.76

4.2

3.8

estimate

0.0

1.90

9874

23406

(3048929) Epstein Barr virus Ab [Presence] in Serum

3149

10569

1.73

157.16

1.4

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2001

5811

1.99

156.54

7.2

5.3

iu/ml

2812.3

1186.5

0.38

318

830

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

371

375

5.66

155.73

1.4

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2880

9458

1.77

154.86

2.9

2.4

91.9

92.2

0.33

2713

8785

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2482

7788

1.85

154.70

5.8

3.9

mg/l

1.7

1.4

27.32

2324

7177

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2848

9344

1.77

153.61

2.0

2.3

g/l

10.2

0.27

2559

7610

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16956

79168

1.29

153.34

1.6

mmol/l

1.4

14.32

15127

66701

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

2003

5868

1.97

152.89

1.4

1.3

u/ml

270.4

252.8

1.75

1341

3688

(3049717) Cytology report of Urine Cyto stain

2987

9967

1.74

152.03

2.6

2.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2008

5909

1.96

151.35

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2008

5913

1.96

151.06

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

24660

120668

1.25

151.00

4.1

3.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

2095

6264

1.93

150.89

1.4

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

1025

2270

2.60

149.83

3.4

2.8

mg/l

84.5

43.3

2.75

765

1607

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1559

4193

2.14

148.99

1.6

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

4762

18041

1.54

146.82

2.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2715

8908

1.77

146.29

3.9

3.2

u/ml

0.3

0.4

4.93

1457

5115

(3021387) Prolactin [Units/volume] in Serum or Plasma

3422

11999

1.66

145.26

1.7

1.6

mu/l

333.4

299.2

2.51

3149

10861

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2362

7448

1.84

144.84

2.2

g/l

0.0

0.02

2207

6758

(3019832) Treponema pallidum Ab [Presence] in Serum

8615

36713

1.38

144.14

1.8

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

1865

5466

1.97

142.11

3.1

2.2

16.5

16.6

0.73

1182

2636

(3027801) Oxygen [Partial pressure] in Arterial blood

7726

32429

1.40

141.11

8.5

7.1

kpa

12.6

12.5

1.01

7442

30827

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7730

32450

1.40

141.08

8.5

7.1

kpa

5.1

3.81

7448

30858

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1218

3022

2.32

140.62

2.1

2.2

32.6

32.7

0.22

1197

3007

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1859

5465

1.96

140.43

1.4

1.3

—

(36660697) Celiac disease serology panel - Serum

6337

25699

1.45

139.93

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2444

7873

1.80

139.87

1.4

1.5

iu/ml

17.0

12.5

0.58

200

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1759

5082

2.00

139.44

3.2

3.3

u/ml

804.5

826.4

0.03

1574

4619

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2038

6200

1.90

139.41

1.7

1.4

u/ml

21.2

19.7

0.12

124

(3009466) Valproate [Moles/volume] in Serum or Plasma

1419

3788

2.16

138.09

6.0

4.5

umol/l

370.3

368.1

0.20

1256

3273

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

588

982

3.43

137.82

4.1

3.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2042

6253

1.89

136.95

1.7

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2569

8476

1.76

135.67

2.3

2.4

g/l

0.7

0.9

1.25

2317

7173

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2817

9547

1.71

135.43

2.5

2.2

ug/l

462.4

550.2

0.65

2637

8892

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2669

8914

1.73

135.13

1.8

1.7

g/l

0.2

0.25

2549

8435

(3004119) Hemoglobin [Mass/volume] in Venous blood

4496

17122

1.53

134.96

4.4

3.3

g/l

128.1

129.8

4.87

4414

16715

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3478

12532

1.61

132.34

1.6

1.5

u/ml

14.1

14.8

0.11

346

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1556

4390

2.04

131.47

3.9

2.8

u/ml

7174.8

2735.2

0.34

255

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

319

332

5.50

130.36

2.3

2.5

—

(3016502) Oxygen saturation in Arterial blood

6940

28984

1.40

129.69

9.0

7.5

95.3

95.8

7.07

6730

27826

(3005322) IgE [Units/volume] in Serum or Plasma

5091

20076

1.48

129.23

1.4

1.3

u/ml

266.5

247.8

0.42

4769

18576

(3014007) Fractional oxyhemoglobin in Arterial blood

4559

17593

1.51

128.47

11.5

8.9

94.1

93.9

0.89

4544

17531

(3003327) Ova and parasites identified in Stool by Light microscopy

3039

10661

1.65

128.42

1.8

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2706

9226

1.70

127.17

1.8

1.6

g/l

1.2

0.25

2594

8760

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

806

1723

2.69

126.04

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1224

3192

2.21

126.00

1.1

iu/ml

1.3

2.2

1.44

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1878

5768

1.88

124.73

1.7

1.4

u/ml

109.8

110.8

0.13

401

1280

(3038515) Glucose [Moles/volume] in Venous blood

1815

5526

1.90

123.74

4.1

3.0

mmol/l

7.5

0.24

1788

5427

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6094

25085

1.42

123.20

2.1

2.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2814

9819

1.66

121.24

1.6

titre

283.9

281.5

0.01

120

395

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2149

6953

1.79

121.02

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1827

5623

1.87

120.55

3.2

2.6

umol/l

33.8

34.2

0.29

1572

4737

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2981

10574

1.63

120.51

1.3

miu/ml

218.3

228.0

0.73

1392

4923

(21494755) Public health laboratory ask at order entry panel

4901

39055

0.69

119.47

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1633

4858

1.94

119.13

1.1

—

(3042733) HLA Ab [Presence] in Serum

502

844

3.41

116.60

5.0

4.8

—

(3010375) cycloSPORINE [Mass/volume] in Blood

602

1139

3.03

116.54

28.6

28.0

ug/l

118.4

119.4

0.11

497

967

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3382

12471

1.57

116.53

2.0

u/l

39.1

39.5

0.43

3045

11115

(40761535) Cells panel - Urine sediment

3057

26587

0.64

116.43

3.7

3.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1486

4332

1.98

114.80

3.4

3.2

1.4

1.5

0.37

1074

3388

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2319

7793

1.72

114.63

2.1

2.2

g/l

37.7

37.8

0.19

2068

6602

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4473

17657

1.47

112.33

11.6

8.8

0.6

0.7

15.98

4437

17560

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

702

1492

2.70

111.01

13.4

11.3

mmol/l

0.6

0.07

652

1378

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1226

3369

2.09

110.91

2.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1168

3149

2.13

110.88

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

2396

8227

1.68

109.49

1.3

titre

111.9

123.0

0.24

187

751

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1591

4830

1.90

109.34

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5162

21050

1.43

109.23

2.4

2.3

au/ml

23.2

23.1

0.02

229

1395

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1104

12361

0.50

108.54

1.4

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4106

16039

1.49

108.49

1.4

1.3

iu/l

25.0

27.1

3.77

3483

13843

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3486

13165

1.54

107.95

3.8

2.9

1.3

0.03

3458

13109

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3421

12923

1.53

105.75

3.8

2.9

0.6

0.7

6.34

3343

12349

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2669

9515

1.62

105.52

1.7

1.6

iu/ml

7.4

5.7

0.10

559

2001

(3034770) Mitochondria Ab [Titer] in Serum

2353

8120

1.67

105.49

1.3

1.2

titre

826.7

986.1

0.46

222

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4430

17729

1.45

103.39

11.6

8.7

1.3

1.4

6.67

4392

17619

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6597

28308

1.36

103.15

4.1

3.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5625

23515

1.39

103.12

3.2

2.8

ng/l

206.2

196.0

0.87

5056

21392

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3313

12502

1.54

102.83

5.6

3.6

44.4

49.3

20.41

3257

12383

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

1061

2840

2.15

102.54

1.2

u/l

64.6

65.9

0.13

804

1861

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1222

3466

2.03

101.75

6.7

6.0

mg/l

11.2

11.4

0.75

1129

3185

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3056

11351

1.56

101.74

1.6

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4719

19237

1.43

99.65

1.3

au/ml

46.3

50.0

0.36

153

826

(40768446) Kidney Pathology biopsy report

535

1038

2.95

99.42

2.0

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2326

8134

1.65

99.09

3.3

3.2

mg/l

39.9

43.7

0.62

1969

6579

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2270

7891

1.66

98.93

3.2

ratio

3.3

5.5

0.63

409

400

(3034860) Kappa light chains.free [Mass/volume] in Serum

2328

8148

1.65

98.84

3.3

mg/l

55.8

69.4

0.69

1968

6589

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3356

12810

1.52

98.75

1.1

u/ml

2.4

12.1

1.90

205

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3904

15382

1.47

98.54

3.6

3.1

u/ml

45.0

49.5

0.61

3785

14840

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1698

5456

1.79

97.68

1.3

1.2

titre

98.5

150.3

0.77

103

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3170

11986

1.53

97.40

1.3

1.2

u/ml

0.9

0.8

0.06

150

1148

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

918

2367

2.23

97.09

1.4

1.3

nmol/l

1.5

1.4

0.54

831

2145

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

354

528

3.84

97.04

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

354

528

3.84

97.04

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

354

528

3.84

97.04

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

354

528

3.84

97.04

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1825

6008

1.75

96.78

1.3

1.2

u/ml

29.9

9.8

1.06

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3091

11645

1.54

96.53

4.9

4.2

mmol/l

24.7

0.58

2889

10807

(3010503) CD19 cells [#/volume] in Blood

694

1579

2.52

96.29

2.5

2.6

e9/l

0.4

0.3

0.55

679

1534

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2551

9246

1.59

94.14

2.1

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1401

4297

1.88

93.33

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1211

3549

1.96

92.16

1.5

1.4

—

(3042517) Benzodiazepines panel - Urine

211

205

5.88

92.04

2.1

3.8

—

(3003396) Base excess in Arterial blood by calculation

7389

32773

1.32

91.83

8.8

7.0

mmol/l

0.7

1.1

15.24

6122

25384

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1588

5101

1.79

91.42

1.7

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2012

6926

1.68

90.91

2.2

2.3

g/l

0.0

0.00

1880

6339

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2034

7027

1.67

90.67

2.2

g/l

0.0

0.15

1885

6357

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1065

2999

2.04

90.41

1.3

nmol/l

33.7

29.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1227

3645

1.93

89.84

1.5

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3781

15096

1.45

88.91

2.5

2.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4231

17278

1.42

88.09

1.1

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

525

1083

2.78

87.78

2.5

1.7

umol/l

155.6

120.3

1.23

277

544

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3545

14025

1.46

87.35

2.4

2.2

u/l

6054.7

5989.7

0.04

1449

5481

(3035637) Corticotropin [Mass/volume] in Plasma

1205

3610

1.92

86.09

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

166

132

7.18

85.50

1.1

1.0

—

(3042631) Mycobacterium sp identified in Specimen

1143

3371

1.95

85.45

2.9

2.5

—

(3015736) pH of Urine

24005

121906

1.19

85.31

3.5

3.2

5.7

5.8

0.23

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1186

3571

1.91

83.50

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1170

3522

1.91

82.43

1.5

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2615

9842

1.53

81.81

3.6

3.4

u/ml

746.1

2164.6

1.21

2282

8406

(3010421) pH of Blood

1952

6856

1.64

81.63

6.2

3.2

7.4

5.74

1714

5834

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

749

1915

2.24

80.87

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

1373

4380

1.80

80.83

1.6

1.4

mmol/l

62.1

64.0

0.82

1103

3468

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

642

1532

2.40

80.81

15.5

12.3

nmol/l

809.7

1826.9

0.78

625

1483

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1166

3532

1.90

80.64

1.5

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

288

424

3.88

80.39

6.3

5.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1687

5726

1.70

80.24

1.7

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1163

3531

1.89

79.89

1.5

1.4

—

(3016228) CD19 cells/100 cells in Blood

489

1024

2.73

79.62

2.1

2.0

9.3

8.2

0.91

476

1001

(3027273) Bicarbonate [Moles/volume] in Venous blood

3429

13734

1.44

79.07

5.1

3.1

mmol/l

25.2

0.05

3313

13323

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1151

3496

1.89

78.97

1.3

—

(3012501) Base excess in Blood by calculation

1736

5965

1.68

78.92

6.2

3.3

mmol/l

2.6

2.4

2.53

1242

3927

(3013290) Carbon dioxide [Partial pressure] in Blood

1736

5967

1.67

78.82

6.2

3.3

kpa

5.1

5.0

5.03

1706

5836

(3027315) Oxygen [Partial pressure] in Blood

1745

6008

1.67

78.73

6.2

3.3

kpa

8.8

8.7

2.26

1715

5877

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2068

7449

1.60

78.15

1.4

mg/l

545.1

536.6

0.11

1983

7092

(21494815) CD4 cells/100 lymphocytes in Specimen

904

2529

2.05

78.13

2.2

40.1

41.2

0.25

102

332

(3029634) Reagin Ab [Titer] in Serum by VDRL

1394

4521

1.77

77.72

2.0

2.2

titre

5.4

7.2

0.34

142

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

666

1647

2.32

77.59

22.4

15.9

nmol/l

2501.2

2935.4

0.11

639

1571

(3013005) Retinol [Moles/volume] in Serum or Plasma

528

1169

2.59

77.42

2.3

1.8

umol/l

1.9

0.13

494

1104

(21494814) CD8 cells/100 lymphocytes in Specimen

477

1004

2.72

76.96

2.1

2.0

—

(3011412) CD3 cells [#/volume] in Blood

977

2829

1.98

76.94

2.4

2.5

e9/l

1.2

0.05

602

1683

(40760888) Immunoglobulin light chains.free panel - Serum

1749

6065

1.66

76.81

3.4

3.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

403

771

2.99

76.80

2.1

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1293

4125

1.80

76.12

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1853

6538

1.63

76.09

1.4

e6/l

28.9

31.5

0.12

1409

5089

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1853

6543

1.63

75.86

1.5

e6/l

1693.4

2267.7

0.31

1510

5311

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1691

5838

1.67

75.51

3.0

1.8

nmol/l

0.9

0.8

1.41

1430

4895

(3045424) Erythrocytes [Presence] in Urine

1472

4895

1.73

75.33

1.6

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5169

22366

1.34

75.29

1.2

iu/ml

151.2

141.2

0.73

1587

8825

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

11173

53299

1.23

75.10

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

472

1010

2.67

73.89

3.0

2.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1793

6324

1.63

73.72

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

1754

6155

1.64

73.57

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1332

4338

1.76

73.24

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5445

23842

1.33

73.06

2.3

2.2

ug/l

7.5

7.2

0.28

4743

20653

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1228

3915

1.80

72.46

1.3

nmol/l

0.2

0.09

247

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2237

8370

1.54

71.76

1.3

1.2

u/ml

42.5

34.1

0.61

120

510

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1743

6152

1.63

71.46

1.5

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2618

10144

1.49

71.31

1.5

1.4

u/l

10.1

9.5

1.23

2139

8247

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1255

4054

1.78

70.92

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

1269

4114

1.77

70.86

2.2

1.7

mmol/l

1.7

1.8

0.61

1229

4019

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1741

6158

1.63

70.78

1.3

1.2

u/ml

6.4

4.7

0.35

142

443

(3006442) Creatine [Moles/volume] in Serum or Plasma

714

1894

2.16

70.68

1.5

umol/l

63.7

71.6

2.35

157

(3041354) Potassium [Moles/volume] in Venous blood

1073

3306

1.86

70.53

2.9

2.2

mmol/l

4.1

0.69

1063

3282

(3035285) Chloride [Moles/volume] in Venous blood

1072

3304

1.86

70.39

2.9

2.2

mmol/l

105.5

105.7

0.44

1061

3280

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1834

6584

1.60

70.23

1.3

mmol/l

3.8

3.7

2.42

1732

6173

(1761482) Bacteria [#/volume] in Urine by Culture

1978

7236

1.57

70.01

4.8

3.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

912

2672

1.96

69.53

3.3

3.2

58.0

58.3

0.15

487

1767

(3034274) Bile acid [Moles/volume] in Serum --fasting

1346

4473

1.73

69.05

2.3

2.2

umol/l

7.0

6.8

0.14

1009

3267

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1411

4757

1.70

68.77

1.3

1.2

u/ml

4.0

3.6

0.30

522

1608

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

555

1335

2.38

68.76

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

554

1334

2.38

68.48

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

554

1334

2.38

68.48

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

554

1334

2.38

68.48

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1420

4805

1.70

68.29

1.6

g/l

0.8

0.21

1125

3594

(3000330) Specific gravity of Urine by Test strip

3548

14678

1.40

68.12

4.2

3.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1214

3947

1.77

67.15

1.3

nmol/l

1.6

1.3

0.16

1175

3810

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2069

7733

1.54

66.66

1.3

1.2

u/ml

10.8

8.7

0.62

387

1120

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6032

27116

1.29

66.52

9.9

7.8

g/l

119.4

122.4

23.46

5901

26049

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

751

2088

2.06

66.05

2.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2040

7620

1.54

65.90

1.3

1.2

u/ml

5.7

7.5

0.45

240

744

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

835

2422

1.98

65.50

1.1

—

(40768443) Skin Pathology biopsy report

3181

13034

1.41

64.47

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

483

1128

2.45

63.74

2.4

1.8

umol/l

27.7

29.1

1.90

471

1085

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

955

2929

1.87

63.69

1.8

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

261

428

3.49

63.12

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

655

1760

2.13

62.87

2.6

2.3

97.4

97.2

0.06

622

1634

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2004

7553

1.53

62.14

1.5

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

138

130

6.06

62.02

2.4

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

763

2186

2.00

61.96

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2910

11818

1.42

61.96

4.2

5.1

1.6

1.7

7.50

2794

11017

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1340

4590

1.68

61.63

1.1

—

(3022689) Creatine [Moles/volume] in Urine

344

685

2.87

61.40

1.6

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

228

346

3.77

61.32

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

617

1651

2.14

59.87

1.6

u/l

7.4

5.7

1.12

298

825

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1343

4643

1.66

59.67

1.3

1.2

u/ml

4.2

3.7

0.72

641

2065

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1289

4419

1.67

59.11

1.1

117.3

118.1

0.33

1200

3960

(3024471) HLA-A [Type]

415

934

2.54

59.08

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

544

1391

2.24

58.88

1.8

1.4

umol/l

22.7

25.4

1.17

526

1318

(1175426) CD3 cells/100 lymphocytes in Blood

776

2285

1.95

58.40

2.1

2.2

72.0

72.6

0.40

758

2190

(3024932) HLA-DR beta [Type]

407

914

2.55

58.20

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

708

2021

2.01

58.11

3.3

3.2

mu/l

25.6

27.9

0.80

672

1882

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2073

7986

1.49

57.97

2.1

2.0

mg/l

10.2

11.1

3.88

1938

7460

(3007930) Methemoglobin/Hemoglobin.total in Blood

2840

11632

1.41

57.59

4.3

5.2

0.8

0.9

39.20

2724

10839

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2696

10947

1.42

57.40

2.1

2.0

ug/l

1.6

2.4

2.92

2390

9615

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3666

15715

1.35

56.25

11.5

9.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

761

2256

1.93

56.20

2.1

12.3

14.0

2.46

288

1195

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1012

3290

1.76

56.05

3.0

2.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2522

10163

1.43

55.97

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

820

2497

1.88

55.95

4.1

3.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1335

4700

1.63

55.30

1.9

1.6

—

(4306422)

1316

4619

1.64

55.17

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4577

20317

1.30

55.04

2.0

1.9

—

(3016750) Collection duration of Urine

561

1496

2.15

54.95

2.7

2.0

min

504.7

498.2

0.83

461

1093

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1051

3479

1.73

54.72

1.6

1.5

57.4

56.4

0.34

700

2191

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1750

6586

1.53

54.62

2.5

2.0

g/l

129.8

131.3

1.43

1310

4742

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

512

1330

2.20

53.46

1.2

1.1

u/l

29.2

22.8

0.82

340

1069

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

899

2873

1.79

52.74

1.4

1.3

mmol/l

12.1

11.8

0.37

238

669

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

598

1664

2.06

52.60

1.3

1.2

u/l

98.0

87.1

1.26

539

1452

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

450

1117

2.30

52.19

1.1

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

959

3137

1.75

52.04

3.0

3.3

nmol/l

7.5

7.2

0.05

935

3035

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

464

1169

2.27

52.04

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

658

1906

1.98

51.93

1.7

1.4

—

(3004775) Volume in Urine collected for unspecified duration

705

2094

1.93

51.82

2.9

2.1

703.3

663.4

1.53

548

1382

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

498

1301

2.19

51.32

1.2

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3635

15783

1.33

51.07

1.1

titre

217.1

202.2

0.12

105

414

(3018572) Chloride [Moles/volume] in Blood

713

7265

0.55

50.93

8.4

6.5

mmol/l

105.1

105.2

0.21

658

6528

(3039000) Anion gap in Blood

713

7264

0.56

50.91

8.4

6.5

mmol/l

11.2

0.05

658

6526

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

169

235

4.11

50.88

7.5

6.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

579

1616

2.05

50.55

1.3

1.2

u/l

24.5

0.01

521

1378

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

505

1336

2.16

50.49

1.2

1.1

u/l

89.7

83.7

0.55

354

1102

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1756

6730

1.50

50.33

1.8

1.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

513

1368

2.15

50.30

1.8

1.9

140.3

140.7

0.04

493

1281

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

817

2576

1.82

50.09

2.3

nmol/l

19.9

19.1

1.06

784

2435

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1757

6745

1.50

49.96

1.4

pmol/l

136.2

123.2

0.63

1709

6578

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4799

34107

0.79

49.85

1.6

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

348

782

2.54

49.80

1.1

1.3

23.5

18.5

0.43

146

(3000475) Leukocytes [#/volume] in Synovial fluid

1784

6879

1.49

49.66

1.6

e6/l

11895.8

13267.6

0.70

1304

5026

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2278

9211

1.42

49.58

1.4

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1154

4034

1.64

49.19

2.6

2.9

u/ml

310.5

640.1

0.67

1104

3843

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

972

3247

1.72

49.05

1.2

1.1

95.1

96.3

0.65

928

3012

(3023410) Appearance of Cerebral spinal fluid

909

3000

1.74

47.88

1.6

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

843

2735

1.77

47.09

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

763

7470

0.58

47.03

3.8

3.2

mg/l

26.8

26.6

0.05

393

4747

(3008898) HLA-B27 [Presence]

2698

11341

1.37

46.78

1.1

—

(3021788) Differential panel - Synovial fluid

1393

5164

1.55

46.56

1.6

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

536

1500

2.04

46.52

1.9

1.7

u/field

3.0

2.3

1.02

266

1191

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

11.08

46.38

9.0

7.3

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

147

198

4.24

46.03

4.3

4.5

mg/l

2.2

2.1

0.06

129

167

(3011985) Renin [Units/volume] in Plasma

1112

3921

1.63

45.84

1.5

1.6

mu/l

62.6

66.6

0.25

996

3520

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2109

8532

1.42

45.76

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1646

6351

1.49

45.68

1.3

1.2

u/ml

44.2

42.0

0.20

152

621

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

594

1738

1.96

45.65

1.6

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

536

1516

2.02

45.24

1.6

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

358

864

2.37

44.27

2.3

2.4

nmol/l

151.1

145.6

0.39

302

787

(3045414) Leukocytes [Presence] in Urine

3157

13711

1.33

44.16

1.9

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

541

1555

1.99

43.72

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1068

3777

1.62

43.54

1.3

1.2

u/ml

50.9

52.6

0.07

242

(42529406) Shigella sp [Presence] in Stool by Culture

2224

9164

1.40

43.46

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

874

2933

1.71

43.45

3.7

3.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2200

9055

1.40

43.27

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

469

1283

2.09

43.23

1.6

1.4

5.6

4.1

0.85

324

(3014765) Yersinia sp identified in Stool by Organism specific culture

2216

9141

1.39

43.03

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1878

7531

1.43

42.76

1.9

iu/l

4.0

21.1

1.43

681

2764

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1299

4838

1.54

42.55

1.1

iu/ml

880.7

2855.1

0.41

325

1034

(3020876) Protein [Mass/time] in 24 hour Urine

713

2274

1.80

42.21

2.0

1.9

g/24h

1.4

1.0

0.61

143

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

703

2236

1.80

42.00

1.2

mmol/l

2.1

0.30

655

2064

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1251

4643

1.55

41.63

1.1

—

(4062490)

898

3075

1.67

41.49

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1116

4038

1.58

41.45

1.1

g/l

1.5

0.17

1029

3640

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

10.87

41.21

8.7

7.9

43.7

46.5

0.20

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

600

1830

1.88

40.90

1.4

1.6

u/ml

23.3

24.8

0.26

390

(3023420) DNA double strand Ab [Units/volume] in Serum

944

3291

1.64

40.75

1.7

1.5

iu/ml

34.3

32.6

0.10

147

(4034850)

1305

10962

0.67

40.73

6.9

9.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

462

1287

2.05

40.67

2.2

2.1

ug/min

64.8

108.9

1.04

107

280

(3027135) IgG subclass 1 [Mass/volume] in Serum

895

3079

1.67

40.65

1.4

1.3

g/l

6.8

6.7

0.58

673

2111

(3028192) IgG subclass 2 [Mass/volume] in Serum

894

3077

1.66

40.53

1.4

1.3

g/l

2.8

3.0

2.52

671

2114

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

721

2337

1.77

40.48

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

893

3077

1.66

40.32

1.4

1.3

g/l

0.4

0.63

675

2116

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

719

2335

1.76

40.12

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

929

3239

1.64

40.09

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

718

2334

1.76

39.93

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

996

3544

1.61

39.66

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

713

2319

1.76

39.59

1.2

—

(3000012) Reticulocyte production index

476

1358

2.00

39.33

1.4

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

711

2318

1.76

39.17

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2074

8603

1.39

38.96

1.2

—

(3023419) Bacteria identified in Sputum by Culture

941

3316

1.63

38.96

2.9

2.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

550

1657

1.90

38.93

1.4

mmol/l

5.6

0.19

519

1568

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

218

436

2.86

38.86

3.1

2.3

mg/l

52.6

48.3

0.11

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1014

3646

1.59

38.69

1.3

1.4

pmol/l

308.0

304.5

0.08

773

2864

(40759836) Histone Ab [Presence] in Serum by Immunoblot

708

2317

1.75

38.51

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1235

4660

1.52

38.17

1.2

—

(4268621)

905

3175

1.63

38.15

2.5

2.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

657

2115

1.78

37.79

1.4

umol/l

12.4

11.9

0.89

618

2008

(3003338) MCHC [Mass/volume]

49475

291588

0.89

37.55

22.8

15.6

g/l

331.9

333.0

137.69

49188

289225

(3022493) Free Hemoglobin [Mass/volume] in Plasma

423

1185

2.04

36.75

5.4

4.6

mg/l

1792.2

2437.6

0.26

317

841

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1024

3739

1.57

36.65

1.7

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

685

2260

1.73

36.27

1.1

mg/l

289.4

421.9

0.50

628

2019

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

733

2472

1.70

35.90

1.2

titre

226.4

181.1

0.66

124

420

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

731

2466

1.70

35.77

1.2

titre

196.4

169.6

0.14

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

771

2646

1.67

35.41

1.6

1.5

mmol/l

7.7

7.5

1.10

544

1463

(3000492) Spirometry study

6496

31443

1.20

35.20

1.5

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

365

984

2.12

35.04

1.8

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

534

1655

1.85

34.76

1.4

1.5

u/l

5.1

5.9

3.54

460

1380

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

185

363

2.91

34.15

6.5

4.4

ug/min

45.9

46.6

0.05

161

277

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

619

2020

1.75

34.07

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

10690

54009

1.15

33.85

3.1

2.8

ug/l

0.7

0.8

1.72

6872

34348

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

162

296

3.12

33.61

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

767

2671

1.64

33.35

1.5

mosm/kgh2o

281.7

280.0

1.17

599

2065

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

3238

23038

0.79

33.35

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1724

7127

1.39

33.08

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

619

2038

1.74

33.07

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

448

1333

1.92

33.00

1.7

1.4

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

576

1858

1.77

32.99

2.9

3.4

nmol/l

134.8

128.7

0.13

567

1818

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

388

1101

2.01

32.65

2.8

2.7

au/ml

184.3

147.4

0.48

159

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

416

1216

1.96

32.26

3.2

3.3

mg/l

7.7

8.1

0.67

344

964

(3025130) Human papilloma virus identified in Specimen

1153

4462

1.48

31.65

1.8

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

910

7805

0.66

31.61

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

447

1350

1.89

31.54

1.7

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

523

1662

1.80

31.50

1.1

nmol/l

2.8

5.7

1.04

103

313

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

897

3292

1.56

31.49

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

458

1399

1.87

31.24

1.1

miu/ml

1498.0

1520.1

0.16

458

1399

(3037756) Immunofixation for Serum or Plasma

1388

5583

1.43

31.16

1.7

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

488

1524

1.83

31.09

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

455

1391

1.87

30.96

1.2

1.1

iu/ml

3.4

4.3

0.81

107

(3007916) DNA double strand Ab [Titer] in Serum

163

316

2.94

30.77

1.4

1.3

titre

271.3

117.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

134

230

3.33

30.64

2.2

2.1

umol/l

1.3

0.92

129

200

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

590

1961

1.72

30.54

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

930

3468

1.54

30.44

2.1

1.7

89.8

90.1

0.55

913

3417

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

491

1550

1.81

30.24

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

591

1972

1.71

30.18

1.1

—

(3044927) Protein electrophoresis panel - Urine

719

2528

1.63

30.17

1.2

—

(40768441) Liver Pathology biopsy report

623

2110

1.69

30.15

1.5

1.3

—

(3016038) Potassium [Moles/volume] in Urine

525

1699

1.77

29.81

1.6

1.3

mmol/l

34.0

34.6

0.19

468

1452

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

513

1650

1.78

29.73

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

2220

9705

1.31

29.60

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

2224

9727

1.31

29.55

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

2225

9733

1.31

29.53

1.5

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

361

1036

1.99

29.52

1.9

162.2

163.3

0.07

347

972

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

640

2196

1.67

29.52

1.3

u/ml

0.8

1.3

1.36

308

928

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

168

340

2.82

29.49

1.2

1.3

—

(3019150) Specific gravity of Urine by Refractometry

11312

71596

0.88

29.33

3.6

3.8

kg/l

1.0

1.42

1858

10588

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

153

295

2.96

29.18

2.5

3.5

mg/l

22.9

22.5

0.12

140

282

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

416

1260

1.89

29.15

1.7

1.4

iu/ml

1930773.7

1953559.1

0.01

(3038026) Centromere Ab [Units/volume] in Serum

654

2268

1.65

28.98

1.3

1.2

u/ml

39.5

53.0

0.49

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

2210

9687

1.31

28.91

1.5

1.4

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

532

1746

1.74

28.82

2.9

2.7

ug/l

30.6

26.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

439

1360

1.85

28.73

1.3

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1880

8061

1.34

28.68

1.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

106

4.52

28.53

9.9

10.1

e6/l

334.4

261.2

0.13

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5130

24755

1.20

28.49

2.4

2.2

nmol/l

11.7

12.6

9.38

4595

22071

(3006922) Hepatitis E virus Ab [Presence] in Serum

626

2157

1.66

28.44

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

684

2414

1.62

28.32

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

684

2414

1.62

28.32

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

684

2414

1.62

28.32

1.7

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

4010

18911

1.22

28.30

1.5

—

(3017732) Neutrophils [#/volume] in Blood

4586

21918

1.21

28.25

3.1

2.6

e9/l

4.2

4.1

0.52

3507

17124

(3002619) Bacteria identified in Specimen by Culture

230

560

2.35

28.15

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1578

6606

1.37

28.10

1.9

1.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

343

985

1.99

28.04

2.1

ug/l

68.5

61.0

0.84

338

959

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

417

1283

1.86

27.90

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

417

1284

1.86

27.83

1.5

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

358

1047

1.95

27.81

1.2

g/l

0.3

0.23

303

818

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.61

27.77

3.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

483

1558

1.77

27.77

1.3

titre

46.1

85.3

1.70

135

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

634

2211

1.64

27.53

1.3

1.2

u/ml

81.0

63.1

0.69

103

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1811

13524

0.76

27.39

2.0

1.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

106

4.41

27.13

24.4

2.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

147

290

2.89

27.02

2.5

3.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

722

2613

1.58

26.99

1.4

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1122

4459

1.44

26.95

1.4

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

633

2219

1.63

26.95

1.3

1.2

u/ml

45.6

41.2

0.19

151

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

421

1316

1.83

26.83

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

421

1317

1.83

26.77

1.4

1.6

—

(4024509)

701

2525

1.59

26.74

1.6

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

335

971

1.97

26.72

1.2

111.1

110.7

0.09

310

861

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1226

4963

1.42

26.63

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

447

1427

1.79

26.63

1.1

1.3

64.5

64.4

0.00

167

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

608

2118

1.64

26.54

1.3

1.2

u/ml

10.1

10.3

0.02

144

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1249

5077

1.41

26.51

1.4

1.3

u/l

25.3

25.8

0.20

1053

4163

(4281824)

797

2965

1.54

26.44

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1824

7884

1.33

26.36

1.5

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

175

386

2.59

26.28

1.9

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

326

942

1.98

26.24

1.3

1.2

g/l

0.5

0.03

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

984

3833

1.47

26.24

1.6

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

774

2869

1.54

26.11

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

487

1607

1.73

25.96

1.3

titre

652.0

409.5

0.40

123

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

616

2167

1.63

25.89

2.5

2.6

e6/l

532.4

534.3

0.03

514

1798

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

386

1188

1.86

25.85

1.8

2.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1009

3962

1.46

25.83

1.8

titre

2797.6

4206.9

0.54

191

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.52

25.83

3.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

312

894

1.99

25.71

3.2

3.7

53.7

51.8

0.70

305

861

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1183

4790

1.41

25.69

3.1

nmol/l

0.8

0.36

910

3709

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

657

2360

1.59

25.38

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

839

3186

1.51

25.35

1.1

au/ml

34.8

67.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1820

7915

1.32

25.22

1.5

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.72

25.20

1.5

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

116

4.08

25.09

3.7

3.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1259

5182

1.39

24.89

1.6

1.4

nmol/l

0.4

1.14

1010

4074

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2122

9451

1.29

24.66

2.4

2.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

302

869

1.99

24.63

3.0

3.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

301

867

1.98

24.48

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1637

7042

1.33

24.48

2.8

2.3

ug/min

137.8

102.7

2.13

1151

4067

(4094501)

1853

8114

1.31

24.45

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

334

1001

1.91

24.27

1.1

92.0

90.2

0.46

170

461

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

328

977

1.92

24.27

1.1

94.2

90.1

1.01

168

456

(3024869) Neuronal Ab [Presence] in Serum

188

448

2.40

24.19

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

261

716

2.08

24.18

1.5

1.3

umol/l

17.1

16.9

0.27

246

629

(3045142) Bone marrow Pathology biopsy report

792

3002

1.51

24.17

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

253

686

2.11

24.15

1.2

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

544

1894

1.64

23.86

1.1

1.2

ratio

1.1

0.68

199

633

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7251

36473

1.15

23.73

4.6

4.2

32.1

32.2

0.27

5317

24810

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

338

1025

1.88

23.73

1.1

1.2

111.3

105.6

1.76

316

919

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

617

2223

1.59

23.59

2.5

2.6

e6/l

738.6

728.4

0.06

295

827

(40762365) Oxygen content in Arterial blood by calculation

163

367

2.54

23.58

3.3

3.1

ml/dl

14.7

14.8

0.24

152

338

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1018

4078

1.43

23.50

1.7

1.6

—

(3012898) Urea [Moles/volume] in Urine

129

257

2.86

23.39

1.4

1.7

mmol/l

168.3

174.4

0.19

116

230

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

634

2304

1.57

23.38

2.0

u/field

2.3

2.2

0.06

225

1047

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

131

3.75

23.35

5.9

4.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

726

2722

1.53

23.33

1.6

1.5

32.2

31.2

0.29

436

1739

(3037692) Legionella sp identified in Specimen by Organism specific culture

305

899

1.94

23.29

1.5

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

477

1616

1.69

23.21

2.6

2.4

u/ml

920.4

1107.0

0.93

472

1592

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

293

857

1.95

22.88

1.8

1.6

au/ml

128.7

140.1

0.12

117

(3050129) First trimester maternal screen panel - Serum or Plasma

2698

12478

1.24

22.87

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

550

1944

1.62

22.76

1.8

1.7

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

658

2428

1.55

22.73

1.1

u/ml

76.9

56.0

—

(3036603) Volume of Urine

553

1964

1.61

22.46

1.7

1.6

1969.3

1925.1

0.22

161

417

(3004716) Salmonella sp identified in Stool by Organism specific culture

3675

17573

1.20

22.43

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

352

1104

1.82

22.31

2.1

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

352

1105

1.82

22.25

2.1

2.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

255

717

2.03

22.21

1.5

1.2

nmol/l

124.3

131.0

0.24

190

529

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

376

1208

1.78

22.05

1.3

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

585

2124

1.57

21.70

2.5

2.6

e9/l

0.2

2.04

508

1807

(1002224) Polysomnography panel

2933

13789

1.22

21.30

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

530

1890

1.60

21.21

1.5

1.4

u/l

13.2

12.6

1.17

520

1818

(3014051) Protein [Presence] in Urine by Test strip

1569

6853

1.31

21.14

2.3

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

352

1124

1.79

21.09

2.2

2.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

747

6143

0.69

20.95

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

321

999

1.84

20.89

1.1

u/ml

28.6

10.7

0.30

206

581

(3012565) Volume of 24 hour Urine

415

1395

1.70

20.85

2.5

2.1

1788.5

2028.7

4.29

382

1247

(3006270) Folate [Moles/volume] in Blood

648

2431

1.52

20.83

1.2

1.1

nmol/l

358.5

371.7

0.81

552

2052

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1353

10117

0.76

20.71

1.5

1.6

—

(3000285) Sodium [Moles/volume] in Blood

139

309

2.57

20.69

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1070

4429

1.38

20.55

1.2

1.3

u/l

41.4

31.6

1.16

956

3848

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

652

2457

1.52

20.54

1.1

mg/l

279.8

266.0

0.37

583

2159

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

354

1144

1.77

20.41

1.4

mu/l

667.7

692.9

0.06

335

1086

(3032057) Clostridioides difficile [Presence] in Stool

204

544

2.14

20.40

2.0

1.8

—

(3051651) Icteric interference index of Serum or Plasma

495

1753

1.61

20.40

4.2

3.9

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

475

1667

1.63

20.30

1.4

1.5

ug/l

7.9

0.00

435

1512

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

294

898

1.87

20.29

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

233

658

2.02

20.12

1.5

1.2

107.6

106.8

0.13

222

622

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

671

2558

1.50

20.03

1.2

1.1

mg/l

41.6

43.4

0.21

575

2142

(3048879) Bone marrow aspiration report

249

725

1.96

19.78

1.7

1.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

506

1816

1.59

19.77

1.4

1.3

umol/l

4.8

5.2

1.68

462

1677

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

357

1169

1.74

19.70

1.4

72.5

73.1

0.32

338

1111

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

890

3605

1.41

19.42

1.5

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1485

6518

1.31

19.35

1.8

1.6

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

110

224

2.80

19.30

1.2

mg/l

53.5

43.8

0.82

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

338

1098

1.76

19.19

2.1

2.0

mg/l

9.1

9.4

0.33

288

858

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1077

4516

1.36

19.14

1.4

1.3

mmol/l

7.3

7.0

1.78

879

3097

(3044941) Cell count panel - Synovial fluid

1074

4502

1.37

19.13

1.5

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

717

2801

1.46

19.01

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

103

204

2.88

18.97

3.0

2.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1152

4889

1.35

18.96

1.1

u/ml

4.1

2.7

1.31

435

2523

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

519

1894

1.57

18.92

1.7

1.8

—

(3025315) Body weight

106

214

2.83

18.89

4.8

4.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

676

2616

1.48

18.80

3.3

2.5

—

(3012441) Differential panel - Pleural fluid

687

2673

1.47

18.60

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

251

751

1.91

18.49

1.9

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

797

3198

1.43

18.36

3.8

3.6

—

(4027681)

527

1944

1.55

18.36

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

311

1004

1.77

18.07

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

822

3327

1.41

18.06

2.1

1.9

ug/l

23.5

24.4

0.15

808

3253

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

810

3273

1.42

17.97

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

307

990

1.77

17.91

2.1

1.5

u/ml

28408.6

23124.1

0.07

113

(3008536) Aspergillus sp Ab [Presence] in Serum

188

516

2.08

17.57

2.0

2.2

—

(4015189)

229

676

1.93

17.57

2.7

2.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.80

17.55

6.7

5.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

217

630

1.97

17.46

1.1

1.2

88.8

89.2

0.04

162

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

242

732

1.89

17.30

1.3

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

328

1091

1.72

17.22

2.4

2.6

ug/l

1.4

1.1

0.69

306

1035

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

239

721

1.89

17.22

2.0

1.9

u/l

35.8

40.1

0.20

225

646

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

175

2.93

17.15

1.6

2.0

ug/g

188.5

159.6

0.75

152

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2831

19112

0.84

17.11

7.7

7.0

mmol/l

24.7

24.6

0.72

2678

17748

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

105

224

2.67

17.00

1.4

1.2

nmol/l

16.8

16.1

0.12

(3014271) Vancomycin [Susceptibility]

387

1352

1.64

16.94

2.9

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

143

357

2.29

16.81

2.4

mmol/l

1.5

1.3

0.44

262

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

136

333

2.33

16.69

1.5

1.3

11.7

12.0

0.04

174

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7273

37394

1.12

16.54

1.8

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

847

3503

1.38

16.47

1.6

1.4

g/l

32.4

33.3

1.15

768

3140

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

483

1793

1.54

16.43

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

462

1700

1.55

16.34

1.1

u/l

1.1

0.01

208

771

(3043409) Potassium [Moles/volume] in Arterial blood

1258

9191

0.78

16.19

5.7

4.3

mmol/l

3.9

1.12

1203

8610

(3011897) Casein IgE Ab [Units/volume] in Serum

199

576

1.97

16.19

1.3

u/ml

3.5

4.7

0.20

136

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.90

16.09

1.5

nmol/l

208.9

308.4

0.53

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

110

249

2.52

15.93

1.5

1.7

mg/l

1.6

1.9

0.27

166

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

334

1143

1.67

15.87

2.4

2.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

275

893

1.76

15.75

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1135

4951

1.31

15.58

1.4

1.3

ug/l

3.8

0.03

1002

4468

(3020191) Ethanol [Moles/volume] in Serum or Plasma

620

2451

1.45

15.57

1.7

1.4

promille

1.6

1.3

5.71

468

1953

(3036670) Protein [Mass/volume] in Synovial fluid

249

788

1.80

15.54

1.2

g/l

38.1

40.6

1.78

131

430

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

865

3629

1.36

15.44

2.0

mg/l

28.4

26.4

0.38

235

956

(3029075) Extractable nuclear Ab panel - Serum

278

914

1.74

15.28

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

210

633

1.89

15.24

1.2

1.1

80.2

76.6

0.40

156

(3002331) Protein [Mass/volume] in Peritoneal fluid

190

555

1.95

15.11

1.4

g/l

27.1

36.7

0.43

143

430

(44806071)

141

368

2.19

15.02

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

469

1767

1.52

14.97

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1145

5032

1.30

14.90

1.6

1.4

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

5.27

14.90

1.7

1.4

nmol/l

297.8

290.7

0.02

(3028433) Virus identified in Specimen by Culture

285

957

1.70

14.57

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

125

314

2.27

14.57

2.0

1.6

mg/l

1.8

1.6

0.52

115

259

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

142

377

2.15

14.53

2.1

2.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

595

2368

1.44

14.47

1.4

1.3

u/l

556.8

488.4

0.25

567

2236

(3018738) Hemoglobin F/Hemoglobin.total in Blood

207

2.59

14.41

2.9

3.4

12.6

12.4

0.01

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

593

2364

1.43

14.30

2.0

1.7

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.70

14.29

4.7

3.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

755

3141

1.37

14.25

1.9

1.6

—

(40768806) Pleura Pathology biopsy report

660

2685

1.40

14.22

1.6

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

172

496

1.98

14.21

2.3

2.5

mmol/l

7.6

7.4

0.22

118

288

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

393

1441

1.56

14.20

1.1

u/ml

9.0

10.0

0.16

256

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

290

988

1.68

14.08

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

424

1585

1.53

14.07

1.7

1.6

nmol/l

1.3

1.2

0.53

337

1241

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

258

852

1.73

14.02

1.5

1.3

67.1

60.7

2.12

197

713

(3003888) Timothy IgE Ab [Units/volume] in Serum

1425

6492

1.26

13.95

1.1

u/ml

5.0

5.7

0.99

823

3368

(3019977) pH of Arterial blood

401

1485

1.54

13.89

2.8

2.4

7.4

2.35

136

489

(21494434) Karyotype in Bone marrow

592

2373

1.43

13.87

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

100

232

2.46

13.85

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1168

5207

1.28

13.68

1.1

au/ml

14.2

11.3

0.50

337

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

162

464

1.99

13.66

1.6

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

234

757

1.76

13.66

1.5

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

393

1457

1.54

13.56

1.1

1.2

u/ml

5.1

15.5

1.58

150

(3033799) Differential panel - Peritoneal fluid

239

780

1.75

13.55

1.9

—

(3034426) Prothrombin time (PT)

296

1025

1.65

13.54

1.3

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

163

471

1.97

13.43

1.3

titre

76.0

181.4

0.67

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1559

7207

1.24

13.42

1.1

u/ml

1.7

1.8

0.13

740

2938

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

532

2104

1.44

13.42

1.1

iu/ml

8.9

8.0

0.35

125

548

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

140

386

2.07

13.09

1.6

—

(3007463) Buprenorphine [Presence] in Urine

3.78

13.08

4.8

11.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1061

4703

1.29

13.02

1.6

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

134

364

2.10

13.01

1.8

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

687

2861

1.37

12.94

1.9

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

202

637

1.81

12.86

1.5

1.4

g/l

14.2

13.1

0.94

159

471

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

102

248

2.35

12.84

1.5

1.7

mg/l

1.6

2.4

0.78

167

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

102

248

2.35

12.84

1.5

1.7

mg/l

0.7

1.0

0.74

171

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

102

248

2.35

12.84

1.5

1.7

mg/l

2.0

3.1

0.98

179

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

102

248

2.35

12.84

1.5

1.7

mg/l

1.7

2.4

0.63

187

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

102

248

2.35

12.84

1.5

1.7

mg/l

1.7

1.8

0.11

178

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

102

248

2.35

12.84

1.5

1.7

mg/l

3.2

4.6

1.34

162

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

102

248

2.35

12.84

1.5

1.7

mg/l

1.0

1.5

0.75

159

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

102

248

2.35

12.84

1.5

1.7

mg/l

2.0

1.8

0.08

152

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

102

248

2.35

12.84

1.5

1.7

mg/l

2.0

3.1

1.32

177

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

516

2050

1.44

12.74

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

119

311

2.18

12.72

1.5

1.6

ug/l

112.7

112.8

0.01

259

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

200

632

1.81

12.65

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1348

6181

1.25

12.53

1.1

u/ml

1.0

1.1

0.21

661

2641

(3028679) Herpes simplex virus Ab [Presence] in Serum

447

1735

1.47

12.46

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1325

6068

1.25

12.45

1.1

u/ml

1.9

2.5

1.05

342

1556

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

753

3208

1.34

12.29

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

968

4273

1.30

12.29

1.5

1.4

—

(40768793) Breast Pathology biopsy report

1421

6579

1.24

12.11

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

141

402

2.00

12.11

1.4

nmol/l

6.3

300316.3

2.78

118

324

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1492

6947

1.23

12.06

2.0

1.8

pmol/l

186.7

198.2

4.04

1398

6639

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.59

12.02

2.1

—

(3051339) Copper [Moles/volume] in Blood

128

2.85

11.77

1.3

umol/l

16.6

16.5

0.06

108

(3030313) Adrenal Ab [Titer] in Serum

110

289

2.17

11.65

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

213

2.38

11.64

1.6

1.3

—

13.3

—

(3022621) pH of Urine by Test strip

4011

20324

1.13

11.56

2.9

2.7

—

(3042301) Urate [Moles/volume] in Synovial fluid

4.68

11.48

1.0

umol/l

344.8

362.9

0.15

(3022229) Phosphate [Moles/volume] in Urine

188

2.46

11.30

2.2

mmol/l

18.3

20.2

0.52

165

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

676

2874

1.34

11.24

4.7

4.6

u/ml

88.2

118.8

0.56

227

863

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

366

1396

1.50

11.18

1.0

1.1

95.7

97.8

0.64

313

1094

(3035320) C reactive protein [Mass/volume] in Body fluid

554

2284

1.39

11.18

2.8

2.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

772

3351

1.32

11.14

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

279

1004

1.59

11.06

1.1

—

(3004451) EKG impression Narrative

334

1255

1.52

10.96

1.4

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

594

2488

1.36

10.89

1.4

1.3

mmol/l

6.5

6.2

1.63

553

2300

(3018133) Calcium [Moles/volume] in Urine

167

525

1.82

10.83

2.6

2.1

mmol/l

2.5

2.6

0.19

148

478

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

193

634

1.74

10.82

1.1

1.2

u/ml

4.7

8.7

0.81

141

457

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

152

2.59

10.70

2.0

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

183

594

1.76

10.69

1.3

mu/l

89.0

82.0

0.12

134

447

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.28

10.61

1.0

1.1

g/l

0.2

0.85

(3010370) Gastrin [Moles/volume] in Serum or Plasma

147

449

1.87

10.44

1.7

1.8

pmol/l

73.6

51.1

0.34

125

374

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

170

545

1.78

10.37

1.6

1.5

nmol/l

0.2

0.12

131

387

(3027231) Wheat IgE Ab [Units/volume] in Serum

214

736

1.66

10.20

1.1

u/ml

0.7

2.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1000

4542

1.26

10.20

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

310

1167

1.52

10.13

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

114

2.80

10.05

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

168

546

1.76

9.82

1.1

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

209

2.27

9.79

1.6

1.7

umol/l

49.2

44.1

0.65

209

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

198

677

1.67

9.68

1.2

pmol/l

374.8

313.1

0.35

151

487

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

190

646

1.68

9.49

1.7

1.5

ug/l

0.4

0.26

121

426

(3013247) Albumin in CSF/Albumin in Serum or Plasma

197

677

1.66

9.46

1.1

mg/g

7.3

7.1

0.12

188

641

(21494890) Protein electrophoresis panel - 24 hour Urine

660

2873

1.31

9.43

1.9

2.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

258

2.10

9.38

1.2

1.3

mmol/l

5.7

6.1

0.26

132

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

160

521

1.75

9.32

1.5

nmol/l

8.3

5.5

0.53

146

503

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

358

1414

1.45

9.29

1.6

nmol/l

18.9

5.3

0.42

285

1188

(3018405) Lactate [Moles/volume] in Arterial blood

2043

10033

1.17

9.28

4.4

4.2

mmol/l

1.4

1.26

1960

9900

(3023487) Leukocytes [#/volume] in Peritoneal fluid

255

939

1.55

9.26

2.2

1.9

e6/l

2899.6

3276.8

0.07

171

632

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

328

1276

1.47

9.20

2.5

2.4

umol/l

55.3

54.0

0.30

265

1072

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

102

287

2.03

9.20

1.3

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

204

713

1.63

9.20

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.26

9.18

3.8

2.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

234

2.15

9.17

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

197

683

1.65

9.17

1.3

ug/l

72.7

302.9

2.70

101

369

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

528

2236

1.35

9.12

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2063

10153

1.16

9.12

1.9

1.7

nmol/l

40.6

40.9

0.23

2024

9910

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2520

12588

1.15

9.08

1.7

1.6

mg/l

4.4

3.3

3.34

1915

8541

(3000060) B lymphocytes [#/volume] in Blood

263

980

1.53

9.07

2.1

2.3

e6/l

364.4

736.4

0.64

162

527

(40763791) Oxygen content in Venous blood by calculation

3.27

9.01

8.1

6.3

ml/dl

11.4

12.9

1.14

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

206

2.21

9.00

2.0

2.3

58.1

59.4

0.10

123

(3029396) Erythrocyte agglutination [Presence] in Blood

265

992

1.52

8.96

3.0

2.9

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

241

885

1.55

8.88

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

241

2.11

8.88

1.1

u/l

19.7

21.0

0.20

157

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

189

2.26

8.88

2.3

3.2

pmol/l

28.5

424.9

0.61

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

200

2.22

8.87

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

118

356

1.89

8.78

1.1

u/ml

4.5

2.7

0.39

275

(3005011) Chlamydia sp Ab [Titer] in Serum

137

435

1.80

8.71

1.6

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

111

329

1.92

8.71

1.0

u/ml

0.2

0.24

208

(40761539) Cells [Type] in Urine sediment by Light microscopy

195

684

1.63

8.70

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1175

5532

1.21

8.67

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

295

1138

1.48

8.67

1.1

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

240

2.09

8.64

1.0

1.1

u/ml

4.8

4.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

228

833

1.56

8.61

2.1

1.8

e6/l

11461.4

11576.6

0.01

127

438

(3023199) Leukocytes [#/volume] in Pleural fluid

726

3245

1.28

8.54

1.6

1.4

e6/l

3698.0

3169.6

0.15

514

2369

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

268

1020

1.50

8.42

1.1

1.0

u/ml

7.6

10.2

0.67

135

(40765096) Chromosome analysis panel by Banding

216

784

1.57

8.40

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2205

10976

1.15

8.39

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

210

758

1.58

8.36

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1941

9575

1.16

8.36

1.1

u/ml

4.9

5.4

0.22

241

1291

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

987

4584

1.23

8.34

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

451

1893

1.36

8.31

1.3

u/l

13.4

14.4

0.27

424

1731

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

132

422

1.78

8.24

1.1

u/ml

0.1

0.4

0.97

253

(3013466) aPTT in Blood by Coagulation assay

171

2.27

8.12

1.1

36.3

36.8

0.21

146

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

311

1230

1.44

8.09

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

305

1202

1.45

8.08

1.1

ng/l

121.5

550.0

2.86

265

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

179

2.23

8.06

1.0

u/ml

0.5

0.6

0.18

167

(3020393) Adenovirus Ag [Presence] in Stool

125

396

1.80

8.05

1.5

1.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

148

493

1.71

8.05

3.6

1.9

mmol/l

1.2

0.20

140

469

(3047189) Immunofixation for 24 hour Urine

305

1205

1.44

7.98

1.9

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

658

2935

1.28

7.92

1.5

1.4

e6/l

49425.5

55426.2

0.21

414

1736

(3010937) Rubella virus Ab [Presence] in Serum

174

2.23

7.83

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

451

1913

1.35

7.80

1.3

1.4

nmol/l

32.2

31.6

0.17

415

1753

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

341

1383

1.41

7.75

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

721

5134

0.80

7.73

2.3

2.5

13.1

0.55

706

5072

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

508

2198

1.32

7.68

1.6

1.9

mg/l

4.1

3.7

1.27

491

2088

(3011397) Hemoglobin [Presence] in Urine by Test strip

13673

74358

1.06

7.65

3.4

3.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

115

361

1.82

7.65

1.1

u/ml

4.2

5.3

0.16

282

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

241

2.01

7.60

1.3

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

345

1408

1.40

7.58

2.3

2.1

ug/l

31.5

216.4

1.63

329

1340

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

155

2.28

7.54

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

224

2.04

7.41

1.1

u/ml

0.7

1.0

0.52

141

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

426

1811

1.34

7.30

1.4

1.3

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

143

2.31

7.28

1.6

1.2

u/l

194.9

1332.4

1.16

129

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

429

1828

1.34

7.24

6.6

6.5

—

(3035880) pH of Pleural fluid

351

1449

1.38

7.23

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.78

7.20

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

129

428

1.72

7.17

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

130

2.37

7.15

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

101

312

1.85

7.10

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

113

2.47

7.09

1.5

nmol/l

23.6

23.8

0.01

113

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

4.18

7.05

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

293

1.87

7.01

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

179

651

1.57

7.00

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

474

2063

1.31

6.93

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

104

2.52

6.93

2.6

—

(3027035) Albumin [Mass/time] in 24 hour Urine

259

1.92

6.84

1.5

1.3

mg/24h

961.6

203.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

163

2.17

6.76

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

725

3339

1.24

6.73

3.0

6.9

mmol/l

7.5

7.3

0.46

626

2682

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.78

6.66

1.0

—

(44806420)

197

741

1.52

6.66

2.2

2.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

255

1.90

6.56

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

154

2.18

6.55

1.1

u/l

171.0

50.9

0.60

118

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

887

4185

1.21

6.54

1.1

u/ml

0.3

0.5

0.54

229

905

(3017509) Phencyclidine [Presence] in Urine

314

1.80

6.45

2.4

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

298

1.82

6.41

2.0

2.2

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.89

6.39

5.6

4.9

mg/l

10.5

4.7

0.86

(44786800) Granulocytes/100 leukocytes in Body fluid

296

1.81

6.28

1.3

26.2

24.3

0.19

230

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

240

1.90

6.20

1.3

ml/s/173m2

1.4

1.5

0.09

158

(3001893) Eosinophils/100 leukocytes in Pleural fluid

197

754

1.49

6.17

1.5

1.3

2.2

2.9

0.71

160

635

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.13

6.15

1.1

1.0

mmol/l

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

108

2.38

6.05

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

255

1031

1.41

6.02

2.9

umol/l

28.4

28.6

0.06

190

793

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

263

1.84

6.02

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

384

1658

1.32

6.02

1.8

2.0

ug/l

3.3

3.9

0.61

323

1474

(3017950) Salicylates [Moles/volume] in Serum or Plasma

3.01

5.99

1.3

2.2

umol/l

1152.3

1958.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

133

469

1.62

5.98

1.2

1.1

pmol/l

3.7

3.5

0.06

(3013166) Neutrophils/100 leukocytes in Synovial fluid

110

1021

0.61

5.95

1.3

1.4

51.9

54.7

0.38

872

(3020618) Glucose [Moles/volume] in Synovial fluid

2.53

5.95

1.0

1.1

mmol/l

5.3

0.03

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

193

1.98

5.85

1.0

1.1

u/l

7.3

10.1

0.79

193

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

205

1.95

5.84

1.0

u/ml

1.9

1.6

0.07

159

(3047181) Lactate [Moles/volume] in Blood

1527

9919

0.87

5.80

5.2

5.7

mmol/l

1.4

1.3

3.71

1380

8762

(40763480) Human metapneumovirus Ag [Presence] in Specimen

140

2.16

5.77

1.5

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1074

5219

1.18

5.76

1.1

u/ml

5.1

4.3

0.40

457

2088

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

129

2.21

5.76

1.1

1.0

21.0

21.7

0.48

120

(40758047) Lysozyme [Mass/volume] in Pleural fluid

215

1.91

5.69

1.2

1.1

mg/l

7.9

10.3

0.97

199

(3027570) Oxalate [Moles/time] in 24 hour Urine

188

1.97

5.63

1.6

1.4

umol/24h

339.0

314.2

0.38

188

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4182

25715

0.92

5.56

3.0

2.6

ml/min/173m2

66.1

67.6

1.18

1968

9683

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

135

490

1.57

5.44

1.3

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

10.45

5.38

1.3

—

(3003129) Base excess in Capillary blood by calculation

180

698

1.47

5.36

1.7

mmol/l

0.7

0.5

0.29

161

665

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

321

1.71

5.32

1.0

1.1

u/ml

0.5

0.00

172

(3017461) Flecainide [Moles/volume] in Serum or Plasma

153

2.05

5.30

2.0

1.7

umol/l

0.7

0.10

117

(3006245) CD3-CD19+ cells/100 cells in Blood

309

1322

1.33

5.23

2.3

11.9

11.0

0.44

299

1227

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.38

5.19

1.4

nmol/l

389.5

592.1

1.83

(3010838) Calcium [Moles/time] in 24 hour Urine

331

1434

1.32

5.14

1.7

1.6

mmol/24h

5.7

5.5

0.10

115

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

117

2.19

5.13

1.2

1.1

mg/l

0.0

0.4

0.53

104

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

117

2.19

5.13

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

474

2152

1.26

5.13

1.3

1.2

—

(3001556) Androgen free Index in Serum or Plasma

103

356

1.65

5.08

1.2

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

192

1.90

5.04

1.2

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

261

1098

1.36

4.96

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

138

2.07

4.94

1.1

—

(3027874) Urate [Moles/volume] in Urine

2.34

4.91

1.1

mmol/l

1.7

8.5

0.51

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.34

4.91

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

162

1.97

4.90

1.1

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

248

1.77

4.88

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.59

4.86

1.0

u/ml

0.3

1.0

0.91

(3020891) Body temperature

1888

11965

0.90

4.83

5.9

4.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

204

1.84

4.78

3.2

2.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

299

1292

1.32

4.77

2.0

2.2

27.0

29.3

2.27

294

1220

(3034988) Calcium [Moles/volume] in Capillary blood

144

548

1.50

4.75

4.3

2.0

mmol/l

1.2

0.39

138

522

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

293

1.69

4.75

3.8

2.7

mg/l

1.4

1.3

0.12

203

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.98

4.74

1.4

1.3

nmol/l

169.8

119.6

0.75

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

7.84

4.72

4.3

2.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

346

1.63

4.71

6.0

5.3

g/mol

628.3

60.9

0.58

321

(1761868) Lipid panel - Serum or Plasma

21607

119963

1.04

4.66

2.7

2.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

525

0.53

4.65

8.3

7.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.38

4.55

1.2

1.3

—

(3024263) Appearance of Synovial fluid

348

1548

1.28

4.51

2.2

1.6

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

100

357

1.60

4.40

1.0

1.1

u/ml

0.4

0.5

0.10

189

(3036312) Salmon IgE Ab [Units/volume] in Serum

202

1.81

4.38

1.1

u/ml

1.3

1.6

0.15

148

(40765089) Chromosome analysis panel - Blood by G-banded

273

1181

1.32

4.37

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

410

2900

0.80

4.36

1.5

1.3

pmol/l

59.0

105.8

0.90

171

866

(3049242) von Willebrand panel - Platelet poor plasma

2.27

4.36

1.5

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

490

0.53

4.31

11.6

7.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

174

702

1.41

4.30

1.4

1.3

21.4

0.00

153

636

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

111

2.11

4.30

1.3

1.7

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

346

1.60

4.30

2.8

3.1

umol/l

38.9

43.1

0.96

294

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

101

364

1.58

4.29

1.0

1.1

u/ml

1.0

3.1

0.56

194

(3045759) Histamine [Moles/volume] in Serum or Plasma

4.56

4.26

1.5

—

(40759632) Porphyrins [Mass/mass] in Stool

3.72

4.23

1.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

153

605

1.44

4.23

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

226

1.74

4.20

1.3

pmol/l

8.6

15.4

1.51

183

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

943

4662

1.16

4.19

3.4

3.6

u/ml

32.6

38.7

0.54

904

4494

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.21

4.17

1.3

1.5

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

148

1.93

4.16

1.1

u/field

1.2

0.02

100

(1617658) Protocol used for examination of sentinel lymph nodes

454

2108

1.23

4.11

1.1

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

110

409

1.53

4.10

3.3

2.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

251

1084

1.32

4.09

1.5

1.4

pmol/l

14.7

14.8

0.06

222

912

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

228

1715

0.76

4.06

1.2

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

220

1.74

4.06

1.1

u/ml

17.9

26.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

220

1.74

4.06

1.1

u/ml

42.0

27.0

0.43

(3017817) Protein [Mass] in Urine collected for unspecified duration

571

2718

1.20

4.03

2.5

0.3

1.1

1.35

(3020874) Milk IgE Ab [Units/volume] in Serum

494

2321

1.21

4.00

1.1

u/ml

2.4

1.9

0.23

192

697

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

3.11

3.99

1.4

1.1

au/ml

187.9

606.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

133

519

1.46

3.96

1.4

1.3

ng/l

82.0

276.6

0.60

318

(3025577) Chromium [Mass/volume] in Blood

358

1630

1.25

3.90

1.8

2.1

ug/l

2.1

2.4

0.59

292

1374

(3016330) Potassium [Moles/time] in 24 hour Urine

119

456

1.49

3.89

1.3

mmol/24h

71.2

81.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

984

4910

1.14

3.87

1.1

u/ml

5.9

5.2

0.36

447

2075

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

117

448

1.49

3.84

1.0

ug/l

79.3

82.6

0.36

366

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

182

1.79

3.81

1.0

u/ml

15.7

19.8

0.43

148

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.13

3.81

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

133

1.93

3.79

1.3

1.2

umol/24h

0.5

0.8

0.32

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

186

778

1.36

3.78

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

180

749

1.37

3.78

2.5

2.6

ng/l

100.6

111.4

0.39

101

415

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

359

1.54

3.73

2.0

—

(40768795) Lymph node Pathology biopsy report

609

2939

1.18

3.72

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

175

1.79

3.72

1.8

2.3

8.9

20.3

2.89

(3017400) Magnesium [Moles/volume] in Urine

2.46

3.72

1.4

1.1

mmol/l

3.0

3.3

0.21

(3012989) Citrate [Moles/time] in 24 hour Urine

2.49

3.66

1.6

1.3

mmol/24h

1.9

2.3

0.63

(36303858) Crystals [Presence] in Urine

2.93

3.66

1.3

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

210

1.71

3.66

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

177

739

1.37

3.65

1.2

titre

200.0

583.3

—

(3052592) Norovirus Ag [Presence] in Stool

649

0.63

3.62

1.2

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

455

1.47

3.59

1.1

—

(4146454)

630

3060

1.18

3.59

2.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

187

791

1.35

3.57

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

336

1.54

3.56

1.3

1.4

—

(3019060) Gas panel - Arterial blood

3218

19621

0.93

3.53

5.0

4.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1668

8637

1.10

3.53

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

151

618

1.39

3.53

1.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

217

1.68

3.51

1.2

29.2

19.6

0.43

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.38

3.49

1.0

u/ml

2.4

0.3

0.51

(40758292) HTLV I+II Ab panel - Serum

132

530

1.42

3.45

1.3

1.4

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

223

1.66

3.43

1.0

1.1

u/ml

9.0

8.3

0.11

143

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

244

1080

1.29

3.40

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

215

1.67

3.39

1.3

1.2

ug/l

112.1

107.4

0.09

137

(3033923) Metanephrine [Moles/time] in 24 hour Urine

151

623

1.38

3.38

1.1

umol/24h

0.7

3.0

0.51

317

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

108

419

1.47

3.38

1.4

1.3

41.0

54.7

1.71

207

(4211845)

357

1656

1.23

3.35

3.0

2.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

702

1.36

3.34

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

148

1.81

3.33

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

111

435

1.46

3.31

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

103

398

1.48

3.30

2.4

2.7

pmol/l

65.3

72.0

0.18

351

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.05

3.29

1.0

u/ml

0.1

0.2

0.59

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

682

0.66

3.28

1.4

1.2

mg/l

93.4

37.2

0.38

497

(3044007) Cell count panel - Peritoneal fluid

183

783

1.33

3.27

1.9

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

285

1.56

3.23

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

106

415

1.46

3.19

2.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.41

3.19

2.1

2.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

246

1.60

3.17

1.0

u/ml

0.6

1.6

0.86

177

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

547

2657

1.17

3.17

1.5

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.98

3.13

1.1

1.0

pmol/l

213.9

215.7

0.01

(3020650) Glucose [Presence] in Urine

116

923

0.72

3.11

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

378

1781

1.21

3.09

1.0

ng/l

814.2

728.5

2.85

277

1189

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

179

773

1.32

3.04

1.3

37.5

39.2

0.26

143

499

(44813793)

498

2410

1.18

3.04

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

378

1785

1.21

3.02

1.0

ng/l

35.0

44.0

4.36

286

1214

(3036180) Methadone [Presence] in Urine

2.39

3.01

2.9

2.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

111

444

1.43

3.01

2.9

2.7

u/l

1836.0

1531.5

0.14

406

(3006462) Nitrate [Presence] in Urine

324

1511

1.22

2.95

3.1

2.9

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.11

2.94

4.9

6.1

mg/l

1.3

0.09

(3041672) Baker's yeast Ab [Presence] in Serum

172

1.69

2.92

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

105

1.90

2.90

1.0

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

243

1.57

2.90

1.2

1.4

u/ml

6.3

7.0

0.05

208

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

125

515

1.38

2.89

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

374

1774

1.20

2.88

1.0

ng/l

276.0

351.7

2.65

290

1224

(3014891) Appearance of Pleural fluid

351

1.46

2.81

2.1

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

355

1685

1.20

2.74

1.4

1.2

u/l

203.9

339.0

2.99

323

1587

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.96

2.73

1.2

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

150

1.71

2.71

1.1

1.0

—

(3020491) Glucose [Moles/volume] in Blood

484

2365

1.17

2.67

1.8

1.7

mmol/l

6.5

6.7

0.67

351

1788

(37019676) Renin [Units/volume] in Plasma --supine

2.15

2.64

1.2

1.0

mu/l

57.4

61.7

0.04

(3028717) Thiamine [Mass/volume] in Blood

305

1.48

2.62

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

156

677

1.31

2.62

1.7

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.00

2.60

1.4

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

264

1.51

2.60

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

153

1.68

2.54

1.0

—

(3049233) Organic acids panel - Urine

2.07

2.54

1.2

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

136

1.72

2.53

1.0

u/ml

0.1

0.2

0.04

(3045788) Cell count panel - Pleural fluid

516

2549

1.16

2.50

1.6

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

176

1.62

2.49

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

176

1.62

2.49

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

13118

76664

0.97

2.47

3.8

4.2

21.5

22.1

3.53

5825

35656

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

314

1.45

2.47

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

182

814

1.28

2.46

1.4

1.3

mmol/l

3.4

3.5

0.34

175

745

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

190

1.59

2.46

1.1

1.2

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.36

2.41

1.1

1.0

u/ml

0.1

0.3

0.39

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

326

1.43

2.38

1.3

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.95

2.37

1.1

1.0

u/ml

0.2

0.1

0.56

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

126

1.72

2.37

1.1

u/l

411.1

438.4

0.05

107

(3032641) Amino acids panel - Urine

2.21

2.35

1.3

1.2

—

(3013762) Body weight Measured

114

1.75

2.32

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.10

2.31

1.4

1.2

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

2.06

2.30

1.7

1.2

mg/l

2.6

6.4

1.09

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

102

1.79

2.28

1.0

u/ml

0.1

0.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

291

1385

1.20

2.25

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

236

1101

1.22

2.24

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.80

2.24

1.1

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

3.80

2.24

1.0

1.2

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.80

2.24

1.1

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

142

1.65

2.21

1.9

1.6

ng/l

178.4

213.0

1.82

122

(3014599) Egg white IgE Ab [Units/volume] in Serum

460

2278

1.15

2.20

1.1

u/ml

4.3

5.2

0.17

149

621

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

394

1.37

2.20

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.38

2.17

1.2

1.3

—

(3011544) Albumin [Mass/volume] in Pleural fluid

229

1.49

2.16

1.1

g/l

16.4

17.6

0.55

208

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

3.00

2.15

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

100

1.77

2.14

1.1

u/field

1.8

1.0

0.44

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.99

2.14

1.0

1.1

u/field

1.3

1.2

0.15

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

126

1.67

2.13

1.0

—

(36304079) Mucus [Presence] in Urine sediment

3.99

2.09

1.1

1.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

185

1.54

2.08

1.7

1.2

pmol/l

16.4

17.1

0.12

158

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

413

1.35

2.08

1.3

1.1

—

(40758358) Immune stain study

127

1.66

2.08

1.0

—

(4133840)

200

926

1.23

2.07

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

114

1.70

2.07

1.2

1.3

u/field

1.2

1.1

0.07

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

136

1.63

2.06

1.5

1.6

u/l

0.0

0.3

1.57

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

340

2259

0.86

2.05

1.2

1.3

g/l

1.4

1.5

0.28

130

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

185

851

1.24

2.04

1.6

ug/l

9.6

8.9

1.46

185

851

(3044416) Complement C4 [Mass/volume] in Pleural fluid

115

1.69

2.02

1.2

g/l

0.1

0.20

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.85

2.00

1.3

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.87

1.99

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

211

1.49

1.96

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

2.25

1.96

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

173

797

1.24

1.91

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

171

1.53

1.90

1.1

1.0

u/ml

35.9

0.4

0.50

(3051101) Glucose [Moles/volume] in Cord blood

544

0.72

1.90

4.3

5.7

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

149

1.57

1.87

1.3

mg/l

1.7

1.6

0.13

125

(3041806) Other cells [#/volume] in Blood by Manual count

244

1647

0.84

1.83

1.5

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

101

1.69

1.83

1.1

nmol/l

195.5

295.1

2.94

101

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

150

684

1.25

1.83

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

301

1.38

1.81

1.5

1.6

—

(3000219) Insulin receptor Ab [Presence] in Serum

4.75

1.81

1.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

4.75

1.81

7.8

5.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

399

1.33

1.80

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

187

875

1.22

1.80

3.8

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

187

875

1.22

1.80

3.8

2.3

—

(3013931) Oligosaccharides [Presence] in Urine

3.33

1.80

1.1

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

124

555

1.27

1.77

2.7

1.5

ug/l

4.7

3.2

0.29

334

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

110

485

1.29

1.76

1.2

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

226

1.44

1.76

1.1

iu/ml

20.8

18.2

0.10

(3001019) Free T4 and TSH panel - Serum or Plasma

3192

19019

0.95

1.74

1.7

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

180

1.49

1.73

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

121

1.60

1.71

1.0

u/ml

0.0

0.1

0.52

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

329

1.35

1.71

1.1

—

(3018291) Platelet Ab [Presence] in Serum

2.03

1.67

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.98

1.67

1.6

1.3

u/field

0.7

0.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

325

2122

0.87

1.62

2.2

1.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

221

1.42

1.61

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.87

1.60

1.3

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.90

1.59

1.1

—

(3045177) Copper [Moles/volume] in Urine

1.98

1.59

1.0

1.1

umol/l

0.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.12

1.51

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

404

0.72

1.51

2.4

u/field

0.8

0.6

0.81

404

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.11

1.51

1.0

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.78

1.48

1.1

1.2

—

(3024316) Viscosity of Plasma

140

1.51

1.48

1.2

1.9

mpas

1.5

1.7

0.55

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

314

1.33

1.45

1.1

umol/24h

1.7

2.9

0.52

314

(3007456) Orange IgE Ab [Units/volume] in Serum

1.69

1.40

1.0

u/ml

0.0

0.2

0.78

(40757373) Influenza virus identified in Isolate

122

564

1.23

1.39

1.9

1.5

—

(3007147) Virus identified in Stool by Electron microscopy

2.85

1.39

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

218

1066

1.17

1.37

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

799

1.19

1.36

1.1

—

(40762814) Titanium [Mass/volume] in Blood

103

469

1.25

1.35

2.2

2.3

ug/l

3.4

3.8

0.37

156

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

118

549

1.23

1.29

5.4

4.6

u/l

45.1

59.2

0.57

209

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

155

742

1.19

1.27

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

150

1.44

1.27

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.19

1.27

1.1

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

228

1.35

1.25

1.1

—

(3019174) dRVVT (LA screen)

283

1.31

1.23

1.1

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

239

1.34

1.22

1.0

u/ml

2.3

0.3

0.49

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

370

1.26

1.20

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.11

1.18

1.3

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

158

1.41

1.16

1.0

u/ml

35.1

0.4

0.49

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.49

1.16

1.3

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

138

662

1.19

1.14

17.9

6.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6745

37588

1.03

1.13

1.5

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.07

1.12

1.3

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.90

1.10

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.90

1.10

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.90

1.10

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.90

1.10

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.90

1.10

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.90

1.10

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.90

1.10

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.54

1.10

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

136

1.43

1.10

1.1

1.2

—

(4212803)

245

1.30

1.06

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.69

1.05

1.4

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

308

1577

1.11

1.04

6.4

5.7

u/ml

272.4

1616.2

1.62

316

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.58

1.04

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

211

1.32

1.04

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

105

1.47

1.01

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

261

1663

0.89

1.00

2.7

2.2

umol/l

24.3

54.5

3.26

148

(3015076) Soybean IgE Ab [Units/volume] in Serum

394

2049

1.10

1.00

1.1

1.0

u/ml

0.4

0.8

0.80

304

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

457

0.80

0.99

1.1

1.2

mmol/l

19.9

20.5

0.78

375

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

2.44

0.98

1.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.44

0.98

1.0

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

132

643

1.17

0.96

1.4

20.7

23.1

0.45

551

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

137

671

1.16

0.94

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

373

1.22

0.93

2.5

2.6

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

137

672

1.16

0.92

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

251

1.27

0.92

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

308

1.24

0.90

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.46

0.89

1.1

1.2

ng/l

8395.0

2894.8

0.59

(3006969) Lambda light chains [Mass/volume] in Urine

1.60

0.88

1.1

1.0

g/l

0.0

0.1

0.50

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.90

0.88

1.1

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

154

1003

0.87

0.88

3.1

3.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

218

1109

1.12

0.87

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

154

1002

0.88

0.87

6.1

6.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

136

671

1.16

0.86

1.2

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

199

1.29

0.83

1.2

1.5

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.63

0.83

1.1

—

(3022670) pH of Venous cord blood

102

0.61

0.81

1.0

—

(3001729) Color of Synovial fluid

236

1.26

0.80

1.3

1.7

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.46

0.78

1.3

1.7

ug/l

255.5

96.4

1.06

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

450

1.18

0.78

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

282

1467

1.10

0.77

3.1

3.3

—

(3044009) aPTT.lupus sensitive (LA screen)

299

1.22

0.77

1.1

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

54348

310727

0.99

0.75

20.0

13.0

39.8

40.1

18.52

43100

231383

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

173

1.29

0.73

1.2

1.4

1.9

1.5

0.17

115

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

214

1.25

0.72

1.1

1.0

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.58

0.70

1.9

1.4

0.7

0.5

—

(4038314)

293

0.80

0.70

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.65

0.70

1.2

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.65

0.70

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.65

0.70

1.2

1.3

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

190

1.26

0.69

1.0

1.2

—

303.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

356

1.19

0.68

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.53

0.68

1.1

1.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

232

1.23

0.67

1.5

43.9

36.7

0.59

155

(3022475) Manganese [Moles/volume] in Blood

191

1.25

0.67

1.1

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

536

2880

1.06

0.66

1.4

e6/l

107832.9

108427.1

0.01

382

1960

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

124

623

1.13

0.66

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

222

1.23

0.66

8.2

4.8

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.43

0.64

6.0

5.4

mmol/l

0.2

0.3

0.89

(3051593) INR in Capillary blood by Coagulation assay

219

1365

0.91

0.63

5.7

10.7

—

(4010399)

3919

22792

0.98

0.63

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

402

1.16

0.62

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

323

1.18

0.62

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

151

773

1.11

0.61

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.48

0.59

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

128

1.29

0.59

7.3

9.5

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.52

0.58

1.1

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

1.71

0.58

1.0

2.5

—

(40761536) Microorganisms panel - Urine sediment

4729

26504

1.02

0.57

5.3

3.4

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.55

0.56

1.1

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

432

0.86

0.56

1.3

1.8

mmol/l

7.3

0.01

152

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.63

0.55

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

431

0.86

0.55

1.4

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

168

1050

0.91

0.55

1.7

1.8

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.38

0.54

1.8

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.37

0.53

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

366

1.15

0.53

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

357

2163

0.94

0.53

1.2

1.1

—

(3003577) Lead [Moles/volume] in Blood

256

1.18

0.51

1.2

1.5

umol/l

0.2

0.08

(3034614) HLA Ag [Interpretation]

1.36

0.50

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

204

1.20

0.50

1.6

1.5

11.8

13.6

0.19

147

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

142

735

1.10

0.50

1.3

—

(42870560) Thyrotropin [Units/volume] in Cord blood

352

1.15

0.50

1.0

mu/l

9.4

8.5

0.40

297

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

205

1.20

0.48

1.1

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

481

2613

1.05

0.46

1.7

1.4

g/l

0.9

0.20

475

2598

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

140

0.77

0.46

1.4

1.2

1.4

0.51

140

(3015183) Erythrocyte sedimentation rate

302

1828

0.94

0.46

1.4

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

1.68

0.44

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

197

1.19

0.44

1.2

1.5

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.43

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

1.58

0.43

1.2

1.0

umol/l

21.0

14.4

—

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.2

—

0.9

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

147

771

1.09

0.42

18.1

6.6

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

106

0.75

0.42

1.0

—

(40768800) Prostate Pathology biopsy report

1008

5577

1.03

0.41

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

506

1.10

0.40

1.2

mmol/l

1.6

1.7

0.19

304

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

205

1.17

0.39

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.35

0.39

1.9

2.5

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.32

0.38

1.0

1.2

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

115

0.79

0.34

1.0

u/ml

5.4

0.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.31

0.34

1.1

1.8

2.7

1.23

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.24

0.34

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

127

0.81

0.33

1.0

u/ml

0.8

0.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

123

651

1.08

0.32

1.9

2.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.71

0.32

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.29

0.31

1.2

1.3

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

205

1.14

0.30

1.2

1.8

0.9

0.6

0.31

162

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

297

1625

1.04

0.27

1.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

409

1.09

0.27

1.2

1.3

mmol/l

1.5

1.3

0.09

259

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.25

0.26

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

129

0.84

0.26

1.0

u/ml

0.6

0.2

0.37

(3035082) Kappa light chains [Mass/volume] in Urine

1.25

0.26

1.1

1.0

g/l

0.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.22

0.25

1.0

1.1

mmol/24h

145.3

144.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

285

1.10

0.25

1.0

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

161

1.13

0.23

1.3

—

19393.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.22

0.0

3.1

—

3.9

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(44790047)

610

3559

0.98

0.22

1.8

1.5

—

(44790049)

610

3558

0.98

0.21

1.8

1.5

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

5.9

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.25

0.21

1.5

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.78

0.20

3.8

2.4

mu/l

3.8

2.2

—

(44790048)

611

3559

0.98

0.20

1.8

1.5

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.21

0.20

1.0

—

(44806118)

611

3557

0.98

0.19

1.8

1.5

—

(3006598) pH of Arterial cord blood

309

0.92

0.19

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

1.19

0.18

9.4

6.2

—

(3013862) HLA-DP [Type]

121

1.13

0.18

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

307

0.93

0.17

1.0

mmol/l

-5.3

-1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

16862

95838

1.00

0.16

4.7

ug/l

3.1

0.01

15385

86186

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

227

1.08

0.15

4.0

4.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

355

1.06

0.15

1.2

1.3

u/l

41.7

180.2

0.90

249

(3032352) Blasts [#/volume] in Cerebral spinal fluid

329

1.06

0.13

2.4

2.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

209

0.93

0.12

1.0

—

(40763590) HLA-DQ beta [Type]

119

1.10

0.12

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

126

0.90

0.12

1.1

1.0

—

(3017704) Immunofixation for Urine

269

1565

0.98

0.11

1.6

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

181

1.07

0.10

1.1

u/l

1.2

3.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

175

1023

0.98

0.10

9.7

5.9

mmol/l

24.5

25.1

1.36

166

908

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

1.14

0.10

1.4

2.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

130

0.92

0.09

1.3

1.2

—

(40760409) HLA-A [Type] by High resolution

121

1.08

0.09

1.0

—

(40760410) HLA-B [Type] by High resolution

121

1.08

0.09

1.0

—

(46236302) HLA-C [Type] by High resolution typing

121

1.08

0.09

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

144

1.07

0.08

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

198

0.95

0.07

1.2

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.87

0.06

1.0

1.1

nmol/24h

104.5

103.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.93

0.04

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1025

5836

1.00

0.01

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.00

0.00

1.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

321

1833

1.00

0.00

2.5

2.8

40.1

39.2

0.23

100

622

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

426

1.00

0.00

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

406

1.00

0.00

8.4

9.5

umol/l

0.5

0.4

0.73

373

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.98

0.00

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1025

5841

1.00

0.00

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.98

0.00

1.8

2.3

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.91

0.00

1.1

titre

1952.9

2160.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.95

0.00

1.0

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_COUNSELLI_MEDICAL_ADVICE_NOT_ELSEW_CLASSIFIED – Persons encountering health services for other counselling and medical advice, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Persons encountering health services for other counselling and medical advice, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Persons encountering health services for other counselling and medical advice, not elsewhere classified (Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_COUNSELLI_MEDICAL_ADVICE_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints